{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:23:56Z","timestamp":1793215436948,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005028.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T00:00:00Z","timestamp":1364428800000}}],"reference-count":506,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005028.pub3","type":"journal-article","created":{"date-parts":[[2013,3,29]],"date-time":"2013-03-29T17:33:00Z","timestamp":1364578380000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Topical treatments for chronic plaque psoriasis"],"prefix":"10.1002","volume":"2015","author":[{"given":"Anne R","family":"Mason","sequence":"first","affiliation":[{"name":"The University of York; Centre for Health Economics; Alcuin A Block Heslington York UK YO10 5DD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Mason","sequence":"additional","affiliation":[{"name":"University of Warwick; Warwick Medical School - Health Sciences; Gibbet Hill Campus Coventry UK CV4 7AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cork","sequence":"additional","affiliation":[{"name":"The University of Sheffield; Academic Unit of Dermatology Research, Department of Infection and Immunity; Beech Hill Road Sheffield UK S10 2RX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Dooley","sequence":"additional","affiliation":[{"name":"Metaxis Ltd; Elmbank Offices, Elmbank Court Main Road Curbridge UK OX29 7NT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Hancock","sequence":"additional","affiliation":[{"name":"Queen's Campus, Durham University; School of Medicine and Health, Wolfson Research Institute; University Boulevard Thornaby Stockton-on-Tees UK TS17 6BH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,3,28]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2340\/0001555561180182","article-title":"Clinical Trial of a Potent Non-Halogenated Topical Steroid, Budesonide","volume":"61","author":"Agrup","year":"1981","journal-title":"Acta Dermato Venereologica"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD005028.pub3-BIB0002|cit2","first-page":"AB174","article-title":"A new topically applied liquor carbonis distillate (coal tar) solution helps reduce regression of plaque psoriasis after 12 weeks of treatment: A 6-week comparison to calcipotriol cream","volume":"60","author":"Alora-Palli","year":"2009","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0003|cit3","first-page":"275","article-title":"Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream","volume":"11","author":"Alora-Palli Maria","year":"2010","journal-title":"American Journal of Clinical Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0004|cit4","first-page":"214","article-title":"Tolerability and cosmetic acceptability of liquor carbonis distillate (coal tar) solution 15% as topical therapy for plaque psoriasis","volume":"85","author":"Brouda","year":"2010","journal-title":"Cutis"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-3083.1998.tb00948.x","article-title":"Clobetasol Propionate Followed by Calcipotriol Is Superior to Calcipotriol Alone in Topical Treatment of Psoriasis","volume":"11","author":"Austad","year":"1998","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0006|cit6","first-page":"139","article-title":"Controlled Trial of the Efficacy and Safety of Calcipotriol Ointment Applied Once or Twice a Day in Psoriasis Vulgaris Studio","volume":"132","author":"Baiocchi","year":"1997","journal-title":"Giornale Italiano di Dermatologia e Venereologia"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1365-2133.1999.02975.x","article-title":"Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator","volume":"141","author":"Barker","year":"1999","journal-title":"British Journal Of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1365-2133.1999.02975.x","article-title":"Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator","volume":"141","author":"Barker","year":"1999","journal-title":"British Journal Of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0009|cit9","first-page":"992","article-title":"Maxacalcitol - a new, potent and safe vitamin D analogue for treatment of psoriasis","volume":"141","author":"Berth-Jones","year":"1999","journal-title":"British Journal Of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/09546630510011739","article-title":"Limited benefit of combined use of tar-based shampoo with 50 microg\/ml calcipotriol solution in scalp psoriasis","volume":"16","author":"Barrett","year":"2005","journal-title":"Journal of Dermatological Treatment"},{"issue":"6 Pt 2","key":"10.1002\/14651858.CD005028.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/0190-9622(91)70320-2","article-title":"Evaluation of Halobetasol Propionate Ointment in the Treatment of Plaque Psoriasis: Report on Two Double-Blind, Vehicle-Controlled Studies","volume":"25","author":"Bernhard","year":"1991","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6 Pt 2","key":"10.1002\/14651858.CD005028.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/0190-9622(91)70320-2","article-title":"Evaluation of Halobetasol Propionate Ointment in the Treatment of Plaque Psoriasis: Report on Two Double-Blind, Vehicle-Controlled Studies","volume":"25","author":"Bernhard","year":"1991","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0013|cit13","doi-asserted-by":"crossref","unstructured":"Bernstein S Donsky H Gulliver W Hamilton D Nobel S Norman R Treatment of mild to moderate psoriasis with Relieva, a Mahonia aquifolium extract--a double-blind, placebo-controlled study American Journal of Therapeutics 2006 121 6","DOI":"10.1097\/00045391-200603000-00007"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2133.1992.tb00126.x","article-title":"A Multicentre, Parallel-Group Comparison of Calcipotriol Ointment and Short-Contact Dithranol Therapy in Chronic Plaque Psoriasis","volume":"127","author":"Berth Jones","year":"1992","journal-title":"British Journal Of Dermatology"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD005028.pub3-BIB0016|cit15","first-page":"AB212","article-title":"An intra-individual safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis. [Abstract P2858.] American Academy of Dermatology 64th Annual Meeting 3-7 March 2006","volume":"54","author":"Beutner","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0015|cit16","first-page":"357","article-title":"An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis","volume":"5","author":"Beutner","year":"2006","journal-title":"Journal of Drugs in Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2230.1993.tb01018.x","article-title":"Occlusion enhances the efficacy of topical calcipotriol in the treatment of psoriasis vulgaris","volume":"18","author":"Bourke","year":"1993","journal-title":"Clinical & Experimental Dermatology"},{"issue":"Suppl 45","key":"10.1002\/14651858.CD005028.pub3-BIB0018|cit18","first-page":"17","article-title":"A Double-Blind Comparison of Topical Calcitriol (3 mcg\/g) and Calcipotriol (50 mcg\/g) in the Treatment of Chronic Plaque Psoriasis Vulgaris","volume":"133","author":"Bourke","year":"1995","journal-title":"British Journal Of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2340\/0001555577228230","article-title":"A Randomized Double-Blind Comparison of the Effects on Systemic Calcium Homeostasis of Topical Calcipotriol (3 Mu G\/G) and Calcipotriol (50 U M\/G) in the Treatment of Chronic Plaque Psoriasis Vulgaris","volume":"77","author":"Bourke","year":"1997","journal-title":"Acta Dermato Venereologica"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0020|cit20","doi-asserted-by":"crossref","unstructured":"Brown AC Koett J Johnson DW Semaskvich NM Holck P Lally D Effectiveness of kukui nut oil as a topical treatment for psoriasis International Journal of Dermatology 2005 684 7","DOI":"10.1111\/j.1365-4632.2005.02634.x"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD005028.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0190-9622(94)70237-3","article-title":"Comparative Study of Calcipotriene (Mc 903) Ointment and Fluocinonide Ointment in the Treatment of Psoriasis","volume":"31","author":"Bruce","year":"1994","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0022|cit22","unstructured":"Siskin SB Efficacy and Safety of Calcipotriol Ointment Compared to Fluocinonide 2nd International Symposium on Calcipotriol Monaco 1993"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1185\/03007997809111920","article-title":"A Double-Blind Comparison of 0.1% Dithranol in a 17% Urea Base (\"Psoradrate\") and Base Alone in the Treatment of Active Chronic Psoriasis","volume":"5","author":"Buckley","year":"1978","journal-title":"Current Medical Research & Opinion"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005028.pub3-BIB0025|cit24","first-page":"175","article-title":"Calcipotriol plus betamethasone dipropionate gel is effective and safe in the treatment of scalp psoriasis (a phase II study). [Abstract P06.57.] 14th Congress of the European Academy of Dermatology and Venereology, 12-15th October 2005, London UK","volume":"19","author":"Buckley","year":"2005","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0024|cit25","doi-asserted-by":"crossref","unstructured":"Buckley C Hoffmann V Shapiro J Saari S Cambazard F Milsgaard M Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study Dermatology 2008 107 13","DOI":"10.1159\/000130425"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/09546630305545","article-title":"Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy","volume":"14","author":"Camarasa","year":"2003","journal-title":"Journal of Dermatological Treatment"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/09546639209088724","article-title":"Treatment of psoriasis with 30% Dead Sea salt lotion","volume":"3","author":"Cheesbrough","year":"1992","journal-title":"Journal Of Dermatological Treatment"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/09546639909056042","article-title":"Comparison of a treatment phase and a follow-up phase of short-contact dithranol and calcipotriol in outpatients with chronic plaque psoriasis","volume":"10","author":"Christensen","year":"1999","journal-title":"Journal Of Dermatological Treatment"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD005028.pub3-BIB0029|cit29","first-page":"AB140","article-title":"Efficacy and safety results from a randomized, double-blind, vehicle-controlled study of clobetasol propionate spray for the treatment of moderate to severe plaque psoriasis of the scalp [Abstract]. Conference: 68th Annual Meeting of the American Academy of Dermatology, AAD Miami, FL United States. Conference Start: 20100305 Conference End: 20100309","volume":"62","author":"Cook-Bolden","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD005028.pub3-BIB0030|cit30","first-page":"AB197","article-title":"Patient satisfaction with clobetasol propionate spray, 0.05% for the management of moderate to severe plaque psoriasis of the scalp [Abstract]. Conference: 70th Annual Meeting of the American Academy of Dermatology San Diego, CA United States. Conference Start: 20120316 Conference End: 20120320","volume":"66","author":"Cook-Bolden","year":"2012","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD005028.pub3-BIB0031|cit31","first-page":"AB157","article-title":"Successful treatment of moderate to severe plaque psoriasis of the scalp with clobetasol propionate spray, 0.05% [Abstract]. Conference: 69th Annual Meeting of the American Academy of Dermatology New Orleans, LA United States. Conference Start: 20110204 Conference End: 20110208","volume":"64","author":"Cook-Bolden","year":"2011","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0032|cit32","first-page":"A9","article-title":"Patient satisfaction with clobetasol propionate spray, 0.05% for the management of moderate to severe plaque psoriasis of the scalp [Abstract]. Conference: 36th Annual Hawaii Dermatology Seminar of the Skin Disease Education Foundation Waikoloa, HI United States. Conference Start: 20120219 Conference End: 20120224.","volume":"31","author":"Cook-Bolden","year":"2012","journal-title":"Seminars in Cutaneous Medicine & Surgery"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0033|cit33","first-page":"A11","article-title":"The effects of clobetasol propionate spray, 0.05% vs. vehicle spray on the signs of plaque psoriasis on the body and scalp [Abstract]. Conference: 36th Annual Hawaii Dermatology Seminar of the Skin Disease Education Foundation Waikoloa, HI United States. Conference Start: 20120219 Conference End: 20120224","volume":"31","author":"Jarratt","year":"2012","journal-title":"Seminars in Cutaneous Medicine & Surgery"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD005028.pub3-BIB0034|cit34","first-page":"AB204","article-title":"The effects of clobetasol propionate spray, 0.05% versus vehicle spray on the signs of plaque psoriasis on the body and scalp [Abstract]. Conference: 70th Annual Meeting of the American Academy of Dermatology San Diego, CA United States. Conference Start: 20120316 Conference End: 20120320","volume":"66","author":"Jarratt","year":"2012","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0035|cit35","unstructured":"NCT00881868 Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp clinicaltrials.gov\/ct2\/show\/NCT00881868 (accessed 2011)"},{"issue":"8","key":"10.1002\/14651858.CD005028.pub3-BIB0036|cit36","first-page":"885","article-title":"Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial","volume":"10","author":"Sofen","year":"2011","journal-title":"Journal of Drugs in Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD005028.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-4362.1997.00070.x","article-title":"Calcipotriol in psoriasis vulgaris: a controlled trial comparing betamethasone dipropionate + salicylic acid","volume":"36","author":"Crosti","year":"1997","journal-title":"International Journal Of Dermatology"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD005028.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/0190-9622(92)70103-M","article-title":"Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris","volume":"26","author":"Cunliffe","year":"1992","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0039|cit39","first-page":"201","article-title":"Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis","volume":"74","author":"Decroix","year":"2004","journal-title":"Cutis"},{"issue":"10","key":"10.1002\/14651858.CD005028.pub3-BIB0040|cit40","first-page":"Ic","article-title":"Treatment of Psoriasis with Topical Calcipotriol","volume":"128","author":"Simone","year":"1993","journal-title":"Giornale Italiano di Dermatologia e Venereologia"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/00015550252948194","article-title":"A new calcipotriol\/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris","volume":"82","author":"Douglas","year":"2002","journal-title":"Acta Dermato Venereologica"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD005028.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/0190-9622(92)70299-U","article-title":"Efficacy and Safety of Calcipotriol (Mc 903) Ointment in Psoriasis Vulgaris. A Randomized, Double-Blind, Right\/Left Comparative, Vehicle-Controlled Study","volume":"27","author":"Dubertret","year":"1992","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.1365-2133.2001.04075.x","article-title":"Rationale for use and clinical responsiveness of hexafluoro-1,25-dihydroxyvitamin D3 for the treatment of plaque psoriasis: a pilot study","volume":"144","author":"Durakovic","year":"2001","journal-title":"British Journal Of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2133.2004.06002.x","article-title":"Topical paricalcitol (19-nor-1 alpha,25-dihydroxyvitamin D2) is a novel, safe and effective treatment for plaque psoriasis: a pilot study","volume":"151","author":"Durakovic","year":"2004","journal-title":"British Journal of Dermatology"},{"issue":"3-4","key":"10.1002\/14651858.CD005028.pub3-BIB0045|cit45","first-page":"65","article-title":"Scalp psoriasis: topical calcipotriol 50 micrograms\/g\/ml solution vs. betamethasone valerate 1% lotion","volume":"20","author":"Duweb","year":"2000","journal-title":"International Journal of Clinical Pharmacology Research"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/030006058301100208","article-title":"Effect of Salicylic Acid on the Activity of Betamethasone-17,21-Dipropionate in the Treatment of Erythematous Squamous Dermatoses","volume":"11","author":"Elie","year":"1983","journal-title":"Journal of International Medical Research"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0047|cit47","first-page":"315","article-title":"Amcinonide Lotion 0.1% in the Treatment of Patients with Psoriasis of the Scalp","volume":"44","author":"Ellis","year":"1988","journal-title":"Current Therapeutic Research - Clinical & Experimental"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2230.1992.tb00194.x","article-title":"Topical fish oil in psoriasis--a controlled and blind study","volume":"17","author":"Escobar","year":"1992","journal-title":"Clinical & Experimental Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0050|cit49","unstructured":"Farkas B Dobozy A Comparison of Tacalcitol with Dithranol 3rd European Hermal Symposium Hamburg 1995"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0049|cit50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/09546639909056009","article-title":"Comparison of tacalcitol ointment with short-contact dithranol therapy in the treatment of psoriasis vulgaris: a randomized multicentre, open prospective study on efficacy and safety","volume":"10","author":"Farkas","year":"1999","journal-title":"Journal of Dermatological Treatment"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD005028.pub3-BIB0051|cit51","first-page":"AB138","article-title":"Calcipotriene foam for the treatment of plaque-type psoriasis: Results of two phase III studies","volume":"62","author":"Feldman","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/11630710-000000000-00000","article-title":"Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: Results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials","volume":"13","author":"Feldman","year":"2012","journal-title":"American Journal of Clinical Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0053|cit53","unstructured":"NCT00689481 Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies clinicaltrials.gov\/ct2\/results?term=NCT00689481 (accessed 2010)"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/11630710-000000000-00000","article-title":"Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: Results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials","volume":"13","author":"Feldman","year":"2012","journal-title":"AMERICAN JOURNAL OF CLINICAL DERMATOLOGY"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD005028.pub3-BIB0055|cit55","first-page":"AB138","article-title":"Calcipotriene foam for the treatment of plaque-type psoriasis: Results of two phase III studies","volume":"62","author":"Feldman","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0056|cit56","unstructured":"NCT00688519 Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies clinicaltrials.gov\/ct2\/results?term=NCT00688519 (accessed 2010)"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1684\/ejd.2010.0948","article-title":"Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study","volume":"20","author":"Fleming","year":"2010","journal-title":"European Journal of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD005028.pub3-BIB0058|cit58","first-page":"969","article-title":"Short- and long-term safety assessment of a two-compound ointment containing calcipotriene\/betamethasone dipropionate (Taclonex\/Daivobet\/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris","volume":"9","author":"Fleming","year":"2010","journal-title":"Journal of Drugs in Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1684\/ejd.2010.0948","article-title":"Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study","volume":"20","author":"Fleming","year":"2010","journal-title":"European Journal of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD005028.pub3-BIB0060|cit60","first-page":"969","article-title":"Short- and long-term safety assessment of a two-compound ointment containing calcipotriene\/betamethasone dipropionate (Taclonex\/Daivobet\/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris","volume":"9","author":"Fleming","year":"2010","journal-title":"Journal of Drugs in Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD005028.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1046\/j.1365-4362.1999.00782.x","article-title":"Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy","volume":"38","author":"Franz","year":"1999","journal-title":"International Journal Of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD005028.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-4362.2000.00986-4.x","article-title":"Clobetasol propionate foam 0.05%: a novel vehicle with enhanced delivery","volume":"39","author":"Franz","year":"2000","journal-title":"International Journal Of Dermatology"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD005028.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1067\/mjd.2000.105561","article-title":"Lack of efficacy of topical mycophenolic acid in psoriasis vulgaris","volume":"42","author":"Geilen","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/120347540300700301","article-title":"The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions","volume":"7","author":"Gottlieb","year":"2003","journal-title":"Journal of Cutaneous Medicine & Surgery"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/09546639709160502","article-title":"A New Aqueous Dithranol Gel for Psoriasis: Comparison with Placebo and Calcipotriol Ointment","volume":"8","author":"Grattan","year":"1997","journal-title":"Journal Of Dermatological Treatment"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/09546639709160502","article-title":"A New Aqueous Dithranol Gel for Psoriasis: Comparison with Placebo and Calcipotriol Ointment","volume":"8","author":"Grattan","year":"1997","journal-title":"Journal Of Dermatological Treatment"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2133.1994.tb03382.x","article-title":"Comparative Effects of Calcipotriol (Mc903) Solution and Placebo (Vehicle of Mc903) in the Treatment of Psoriasis of the Scalp","volume":"130","author":"Green","year":"1994","journal-title":"British Journal Of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0011-393X(05)80731-3","article-title":"Controlled Evaluation of 0.05% Desonide Lotion and Desonide Cream in Psoriasis","volume":"53","author":"Greenspan","year":"1993","journal-title":"Current Therapeutic Research - Clinical & Experimental"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jaad.2004.06.010","article-title":"Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: A double-blind, randomized study","volume":"51","author":"Gribetz","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD005028.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0149-2918(00)83065-9","article-title":"A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis","volume":"22","author":"Guenther","year":"2000","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1365-2133.2002.04967.x","article-title":"Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial","volume":"147","author":"Guenther","year":"2002","journal-title":"British Journal Of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0072|cit72","doi-asserted-by":"crossref","unstructured":"Van De Kerkhof PCM Once daily vs. twice daily applications of topical treatments in psoriasis [15] British Journal of Dermatology 2005 1245","DOI":"10.1111\/j.1365-2133.2005.06972.x"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2133.2004.06134.x","article-title":"The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet\/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial","volume":"151","author":"Kerkhof","year":"2004","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0074|cit74","unstructured":"Van de Kerkhof PCM A fixed combination of calcipotriol\/betamethasone dipropionate improves quality of life in patients with psoriasis vulgaris 11th Congress of the European Academy of Dermatology and Venereology; 2002 Oct 2-6; Prague 2002 27 2"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1365-2133.2002.04967.x","article-title":"Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial","volume":"147","author":"Guenther","year":"2002","journal-title":"British Journal Of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0076|cit76","doi-asserted-by":"crossref","unstructured":"Van De Kerkhof PCM Once daily vs. twice daily applications of topical treatments in psoriasis [15] British Journal of Dermatology 2005 1245","DOI":"10.1111\/j.1365-2133.2005.06972.x"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2133.2004.06134.x","article-title":"The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet\/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial","volume":"151","author":"Kerkhof","year":"2004","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0078|cit78","unstructured":"Van de Kerkhof PCM A fixed combination of calcipotriol\/betamethasone dipropionate improves quality of life in patients with psoriasis vulgaris 11th Congress of the European Academy of Dermatology and Venereology; 2002 Oct 2-6; Prague 2002 P27 2"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0079|cit79","first-page":"419","article-title":"A randomized controlled multicenter clinical trial on tazarotene gel versus calcipotriol ointment in the treatment of plaque psoriasis vulgaris","volume":"17","author":"Han","year":"2001","journal-title":"Chinese Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0080|cit80","first-page":"152","article-title":"Comparative Effects of Two Different Calcipotriol (Mc 903) Cream Formulations Versus Placebo in Psoriasis Vulgaris. A Randomised, Double-Blind, Placebo-Controlled, Parallel Group Multi-Centre Study 1","volume":"6","author":"Harrington","year":"1996","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0081|cit81","doi-asserted-by":"crossref","unstructured":"Helfrich YR Kang S Hamilton TA Voorhees JJ Topical becocalcidiol for the treatment of psoriasis vulgaris: a randomized, placebo-controlled, double-blind, multicentre study British Journal of Dermatology 2007 369 74","DOI":"10.1111\/j.1365-2133.2007.08037.x"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2133.1993.tb03338.x","article-title":"Highly purified omega-3-polyunsaturated fatty acids for topical treatment of psoriasis. Results of a double-blind, placebo-controlled multicentre study","volume":"129","author":"Henneicke-von Zepelin","year":"1993","journal-title":"British Journal Of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0190-9622(95)90186-8","article-title":"Calcipotriene ointment 0.005% for psoriasis: A safety and efficacy study","volume":"32","author":"Highton","year":"1995","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1468-3083.2006.01541.x","article-title":"Calcipotriol ointment under occlusion gives a fast onset of action","volume":"20","author":"Hinds\u00e9n","year":"2006","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1468-3083.2006.01541.x","article-title":"Calcipotriol ointment under occlusion gives a fast onset of action","volume":"20","author":"Hinds\u00e9n","year":"2006","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1046\/j.1365-2133.2003.05437.x","article-title":"Topical PTH (1-34) is a novel, safe and effective treatment for psoriasis: a randomized self-controlled trial and an open trial","volume":"149","author":"Holick","year":"2003","journal-title":"British Journal of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD005028.pub3-BIB0087|cit87","first-page":"691","article-title":"Calcipotriol betamethasone ointment in the treatment of psoriasis vulgaris: a randomized, double-blind, active-controlled, parallel group study","volume":"42","author":"Huang","year":"2009","journal-title":"Zhonghua Pifuke Zazhi (Chinese Journal of Dermatology)"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000018457","article-title":"The efficacy, safety and tolerance of calcitriol 3 microg\/g ointment in the treatment of plaque psoriasis: a comparison with short-contact dithranol","volume":"201","author":"Hutchinson","year":"2000","journal-title":"Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0089|cit89","first-page":"367","article-title":"Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis","volume":"3","author":"Jarratt","year":"2004","journal-title":"Journal of Drugs in Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0090|cit90","first-page":"A11","article-title":"The effects of clobetasol propionate spray, 0.05% vs. vehicle spray on the signs of plaque psoriasis on the body and scalp [Abstract]. Conference: 36th Annual Hawaii Dermatology Seminar of the Skin Disease Education Foundation Waikoloa, HI United States. Conference Start: 20120219 Conference End: 20120224","volume":"31","author":"Jarratt","year":"2012","journal-title":"Seminars in Cutaneous Medicine & Surgery"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0091|cit91","unstructured":"Jarratt MT Clark SD Savin RC Swinyer LJ Safley CF Brodell RT Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis Cutis 2006 348 54"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2340\/0001555572449450","article-title":"One-Minute Dithranol Therapy in Psoriasis: A Placebo-Controlled Paired Comparative Study","volume":"72","author":"Jekler","year":"1992","journal-title":"Acta Dermato Venereologica"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005028.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0151-9638(09)74549-1","article-title":"A new treatment in scalp psoriasis: Xamiol (R) formulation and results at 8 weeks","volume":"136","author":"Combemale","year":"2009","journal-title":"Annales de Dermatologie et de Venereologie"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0094|cit94","doi-asserted-by":"crossref","unstructured":"Jemec GBE Burden D Poulin Y Ortonne JP A new scalp formulation of calcipotriene plus betamethasone in the treatment of scalp psoriasis compared to its active ingredients and the vehicle [Abstract P2733.] American Academy of Dermatology 65th Annual Meeting 2-6 February 2007 Journal of the American Academy of Dermatology 2007 AB182","DOI":"10.1016\/j.jaad.2006.10.832"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0095|cit95","doi-asserted-by":"crossref","unstructured":"Jemec GBE Ganslandt C Ortonne J-P Poulin Y Burden AD de Unamuno P A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial Journal of the American Academy of Dermatology 2008 455 63","DOI":"10.1016\/j.jaad.2008.04.027"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005028.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0151-9638(09)74549-1","article-title":"A new treatment in scalp psoriasis: Xamiol (R) formulation and results at 8 weeks","volume":"136","author":"Combemale","year":"2009","journal-title":"Annales de Dermatologie et de Venereologie"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0097|cit97","doi-asserted-by":"crossref","unstructured":"Jemec GBE Burden D Poulin Y Ortonne JP A new scalp formulation of calcipotriene plus betamethasone in the treatment of scalp psoriasis compared to its active ingredients and the vehicle [Abstract P2733.] American Academy of Dermatology 65th Annual Meeting 2-6 February 2007 Journal of the American Academy of Dermatology 2007 AB182","DOI":"10.1016\/j.jaad.2006.10.832"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0098|cit98","doi-asserted-by":"crossref","unstructured":"Jemec GBE Ganslandt C Ortonne J-P Poulin Y Burden AD de Unamuno P A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial Journal of the American Academy of Dermatology 2008 455 63","DOI":"10.1016\/j.jaad.2008.04.027"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0099|cit99","doi-asserted-by":"crossref","unstructured":"Gottschalk RW Johnson LA Calcitriol 3 micrograms\/g versus calcipotriol 50 micrograms\/g for plaque psoriasis: treatment, maintenance and cost [Abstract P2720.] American Academy of Dermatology 65th Annual Meeting 2-6 February 2007 Journal of the American Academy of Dermatology 2007 AB179","DOI":"10.1016\/j.jaad.2006.10.819"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0100|cit100","unstructured":"Ji S Chen X Wang B Jin H Zhao G Wang Y Calcitriol ointment versus calcipotriol ointment in the treatment of psoriasis: a single-blind, randomized, multicenter trial Zhonghua Pifuke Zazhi (Chinese Journal of Dermatology) 2008 153 6"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005028.pub3-BIB0101|cit101","first-page":"172","article-title":"A comparison of the efficacy and safety of twice daily applications of calcitriol 3 lg\/g ointment versus calcipotriol 50 mcg\/g ointment in subjects with mild to moderate chronic plaque-type psoriasis. [Abstract P0647.] 14th Congress of the European Academy of Dermatology and Venereology, 12-15th October 2005, London, UK","volume":"19","author":"Xuejun","year":"2005","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0102|cit102","doi-asserted-by":"crossref","unstructured":"Zhu X Wang B Zhao G Gu J Chen Z Briantais P An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg\/g ointment vs. calcipotriol 50 microg\/g ointment in subjects with mild to moderate chronic plaque-type psoriasis Journal of the European Academy of Dermatology & Venereology 2007 466 72","DOI":"10.1111\/j.1468-3083.2006.01913.x"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0103|cit103","first-page":"36","article-title":"A Randomized, Placebo Controlled, Double Blind Trial Study on IL-8 Monoclonal Antibody Cream in the Treatment of Psoriasis Vulgaris","volume":"17","author":"Jin","year":"2001","journal-title":"Chinese Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0104|cit104","first-page":"55","article-title":"Clobetasol propionate emollient 0.05 percent: hypothalamic-pituitary-adrenal-axis safety and four-week clinical efficacy results in plaque-type psoriasis","volume":"60","author":"Jorizzo","year":"1997","journal-title":"Cutis"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0105|cit105","doi-asserted-by":"crossref","unstructured":"Jorizzo J Efficacy with calcipotriene and betamethasone dipropionate ointment in patients with moderate and severe psoriasis [Abstract P2780.] American Academy of Dermatology 65th Annual Meeting 2-6 February, 2007 Journal of the American Academy of Dermatology 2007 AB194","DOI":"10.1016\/j.jaad.2006.10.881"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2133.1998.02029.x","article-title":"Calcipotriene-Induced Improvement in Psoriasis Is Associated with Reduced Interleukin-8 and Increased Interleukin-10 Levels within Lesions","volume":"138","author":"Kang","year":"1998","journal-title":"British Journal Of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2133.1993.tb11852.x","article-title":"Efficacy of topical 5% liquor carbonis detergens vs. its emollient base in the treatment of psoriasis","volume":"129","author":"Kanzler","year":"1993","journal-title":"British Journal Of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD005028.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/archderm.1987.01660340070022","article-title":"Betamethasone Dipropionate in Optimized Vehicle. Intermittent Pulse Dosing for Extended Maintenance Treatment of Psoriasis","volume":"123","author":"Katz","year":"1987","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000247698","article-title":"Intermittent corticosteroid maintenance treatment of psoriasis: a double-blind multicenter trial of augmented betamethasone dipropionate ointment in a pulse dose treatment regimen","volume":"183","author":"Katz","year":"1991","journal-title":"Dermatologica"},{"issue":"6 Pt 2","key":"10.1002\/14651858.CD005028.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0190-9622(91)70321-R","article-title":"A double-blind, vehicle-controlled paired comparison of halobetasol propionate cream on patients with plaque psoriasis","volume":"25","author":"Katz","year":"1991","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000066440","article-title":"A New Calcipotriol\/Betamethasone Dipropionate Formulation (Daivobet(TM)) Is an Effective Once-Daily Treatment for Psoriasis vulgaris","volume":"205","author":"Kaufmann","year":"2002","journal-title":"Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000066440","article-title":"A New Calcipotriol\/Betamethasone Dipropionate Formulation (Daivobet(TM)) Is an Effective Once-Daily Treatment for Psoriasis vulgaris","volume":"205","author":"Kaufmann","year":"2002","journal-title":"Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0113|cit113","first-page":"1054","article-title":"Comparative Study of Calcipotriol and Desoxymethasone Ointments in the Treatment of Psoriasis Vulgaris. The Clinical Effect and Immunohistochemical Change","volume":"32","author":"Kim","year":"1994","journal-title":"Korean Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0114|cit114","first-page":"946","article-title":"A randomized double blind parallel group dose-ranging comparison of the efficacy and safety of calcipotriene solution in the treatment of scalp psoriasis [Abstract 844]","volume":"106","author":"Carder","year":"1996","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0115|cit115","unstructured":"Kiss I McCreary HL Siskin SB Epinette WW A Randomized, Double- Blind, Parallel Group, Dose-Ranging Comparison of the Efficacy and Safety of Calcipotriene Solution in the Treatment of Scalp Psoriasis. 54th Annual Meeting of the American Academy of Dermatology, 10-15 February 1996 Journal of the American Academy of Dermatology 1996 P301"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1365-2133.1994.tb04982.x","article-title":"Comparative effects of calcipotriol solution (50 micrograms\/ml) and betamethasone 17-valerate solution (1 mg\/ml) in the treatment of scalp psoriasis","volume":"131","author":"Klaber","year":"1994","journal-title":"British Journal Of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/095466300300165192","article-title":"Calcipotriol (DovonexR) scalp solution in the treatment of scalp psoriasis: Comparative efficacy with 1% coal tar\/1% coconut oil\/0.5% salicylic acid (CapasalR) shampoo, and long-term experience","volume":"11","author":"Klaber","year":"2000","journal-title":"Journal Of Dermatological Treatment"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0118|cit118","doi-asserted-by":"crossref","unstructured":"Koo J Blum RR Lebwohl M A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes Journal of the American Academy of Dermatology 2006 637 41","DOI":"10.1016\/j.jaad.2006.05.026"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/09546639709160537","article-title":"Calcipotriol ointment vs clobetasol solution in scalp psoriasis","volume":"8","author":"K\u00f6se","year":"1997","journal-title":"Journal Of Dermatological Treatment"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2133.1988.tb03204.x","article-title":"Improvement of Psoriasis by a Topical Vitamin D3 Analogue (Mc 903) in a Double-Blind Study","volume":"119","author":"Kragballe","year":"1988","journal-title":"British Journal Of Dermatology"},{"issue":"8735","key":"10.1002\/14651858.CD005028.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0140-6736(91)92157-W","article-title":"Double-blind, right\/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris","volume":"337","author":"Kragballe","year":"1991","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0122|cit122","first-page":"379","article-title":"Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study","volume":"135","author":"Glade","year":"1996","journal-title":"British Journal Of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1365-2133.1998.02461.x","article-title":"Calcipotriol Cream with or without Concurrent Topical Corticosteroid in Psoriasis: Tolerability and Efficacy","volume":"139","author":"Kragballe","year":"1998","journal-title":"British Journal Of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0124|cit124","doi-asserted-by":"crossref","unstructured":"Van de Kerkhof PC Calcipotriol cream and concurrent corticosteroids in psoriasis Journal of the European Academy of Dermatology & Venereology 1995 S184","DOI":"10.1016\/0926-9959(95)96533-E"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2133.2004.05986.x","article-title":"Efficacy of once-daily treatment regimens with calcipotriol\/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris","volume":"150","author":"Kragballe","year":"2004","journal-title":"British Journal of Dermatology"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD005028.pub3-BIB0126|cit126","first-page":"AB216","article-title":"Correlation between amount of drug used versus efficacy of calcipotriene\/betamethasone in severe psoriasis during a 52-week study [Abstract P2873.] American Academy of Dermatology 64th Annual Meeting 3-7 March, 2006","volume":"54","author":"Gold","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0127|cit127","doi-asserted-by":"crossref","unstructured":"Kragballe K Austad J Barnes L Bibby A de la Brassinne M Cambazard F A 52-week randomized safety study of a calcipotriol\/betamethasone dipropionate two-compound product (Dovobet\/Daivobet\/Taclonex) in the treatment of psoriasis vulgaris British Journal of Dermatology 2006 1155 60","DOI":"10.1111\/j.1365-2133.2006.07236.x"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0128|cit128","doi-asserted-by":"crossref","unstructured":"Kragballe K Austad J Barnes L Bibby A de la Brassinne M Cambazard F Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol\/betamethasone dipropionate two-compound product (Daivobet\/Dovobet\/Taclonex) in the treatment of psoriasis vulgaris Dermatology 2006 319 26","DOI":"10.1159\/000096069"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD005028.pub3-BIB0129|cit129","first-page":"AB220","article-title":"Long-term efficacy of a calcipotriene\/betamethasone dipropionate two compound product in Psoriasis vulgaris [Abstract P2891] American Academy of Dermatology 64th Annual Meeting 3-7 March, 2006","volume":"54","author":"Kragballe","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD005028.pub3-BIB0130|cit130","first-page":"AB172","article-title":"A calcipotriol plus betamethasone dipropionate scalp formulation significantly reduces itching in scalp psoriasis","volume":"60","author":"Kragballe","year":"2009","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2133.2009.09116.x","article-title":"Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial","volume":"161","author":"Kragballe","year":"2009","journal-title":"British Journal of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD005028.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1468-3083.2009.03221.x","article-title":"Quality of life in patients with scalp psoriasis treated with calcipotriol\/betamethasone dipropionate scalp formulation: a randomized controlled trial","volume":"23","author":"Ortonne","year":"2009","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0133|cit133","doi-asserted-by":"crossref","unstructured":"Kreuter A Sommer A Hyun J Brautigam M Brockmeyer NH Altmeyer P 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study Archives of Dermatology 2006 1138 43","DOI":"10.1001\/archderm.142.9.1138"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0134|cit134","doi-asserted-by":"crossref","unstructured":"Kreuter A Sommer A Hyun J Brautigam M Brockmeyer NH Altmeyer P 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study Archives of Dermatology 2006 1138 43","DOI":"10.1001\/archderm.142.9.1138"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archderm.134.1.57","article-title":"The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis","volume":"134","author":"Krueger","year":"1998","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0136|cit136","unstructured":"Lahfa M Mrowietz U Koenig M Simon JC Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis European Journal of Dermatology 2003 261 5"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0138|cit137","unstructured":"Landi G Efficacy and safety of calcipotriol ointment compared to clobetasol ointment in psoriasis vulgaris 3rd Congress of the European Academy of Dermatology & Venereology Copenhagen, Denmark 1993 199"},{"issue":"9","key":"10.1002\/14651858.CD005028.pub3-BIB0137|cit138","first-page":"89","article-title":"Calcipotriol, a New Topical Product in the Therapy of Psoriasis: Controlled Study Versus Clobetasol","volume":"128","author":"Landi","year":"1993","journal-title":"Giornale Italiano di Dermatologia e Venereologia"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0190-9622(83)70059-9","article-title":"Once-Daily Treatment of Psoriasis with Topical Glucocorticosteroid Ointments","volume":"8","author":"Lane","year":"1983","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0140|cit140","doi-asserted-by":"crossref","unstructured":"Langley R Gupta A Papp K Wexler D \u00d8sterdal M \u0106ur\u010di\u0107 D Calcipotriol plus Betamethasone Dipropionate Gel Compared with Tacalcitol Ointment and the Gel Vehicle Alone in Patients with Psoriasis Vulgaris: A Randomized, Controlled Clinical Trial Dermatology 2011 148 56","DOI":"10.1159\/000323408"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD005028.pub3-BIB0141|cit141","first-page":"AB134","article-title":"Efficacy and safety of calcipotriene plus betamethasone dipropionate gel compared to tacalcitol ointment and gel vehicle alone in patients with psoriasis vulgaris: A randomized controlled trial","volume":"62","author":"Langley","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0142|cit142","unstructured":"NCT00670241 Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and the Gel Vehicle Alone in Patients With Psoriasis Vulgaris clinicaltrials.gov\/ct2\/results?term=NCT00670241 (accessed 2010)"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0143|cit143","doi-asserted-by":"crossref","unstructured":"Langley R Gupta A Papp K Wexler D \u00d8sterdal M \u0106ur\u010di\u0107 D Calcipotriol plus Betamethasone Dipropionate Gel Compared with Tacalcitol Ointment and the Gel Vehicle Alone in Patients with Psoriasis Vulgaris: A Randomized, Controlled Clinical Trial Dermatology 2011 148 56","DOI":"10.1159\/000323408"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD005028.pub3-BIB0144|cit144","first-page":"AB134","article-title":"Efficacy and safety of calcipotriene plus betamethasone dipropionate gel compared to tacalcitol ointment and gel vehicle alone in patients with psoriasis vulgaris: A randomized controlled trial","volume":"62","author":"Langley","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0145|cit145","unstructured":"NCT00670241 Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and the Gel Vehicle Alone in Patients With Psoriasis Vulgaris clinicaltrials.gov\/ct2\/results?term=NCT00670241 (accessed 2010)"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/09546639209088718","article-title":"1 Alpha 25-Dihydroxyvitamin D-3 (Calcitriol) Ointment in Psoriasis","volume":"3","author":"Langner","year":"1992","journal-title":"Journal Of Dermatological Treatment"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1365-2133.1993.tb00237.x","article-title":"Topical Calcitriol in the Treatment of Chronic Plaque Psoriasis: A Double-Blind Study","volume":"128","author":"Langner","year":"1993","journal-title":"British Journal Of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0148|cit148","first-page":"11","article-title":"Efficacy and tolerance of topical calcitriol 3 microg g(-1) in psoriasis treatment: a review of our experience in Poland","volume":"58","author":"Langner","year":"2001","journal-title":"British Journal Of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0149|cit149","first-page":"11","article-title":"Efficacy and tolerance of topical calcitriol 3 microg g(-1) in psoriasis treatment: a review of our experience in Poland","volume":"58","author":"Langner","year":"2001","journal-title":"British Journal Of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/030006059101900207","article-title":"A double-blind study comparing oleum horwathiensis with placebo in the treatment of psoriasis","volume":"19","author":"Lassus","year":"1991","journal-title":"Journal of International Medical Research"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0151|cit151","first-page":"168","article-title":"A randomized, double-blind placebo-controlled study of the safety and efficacy of clobetasol propionate 0.05% foam in the treatment of non-scalp psoriasis","volume":"14","author":"Lebwohl","year":"2001","journal-title":"Skin Pharmacology & Applied Skin Physiology"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-4362.2002.01431.x","article-title":"A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis","volume":"41","author":"Lebwohl","year":"2002","journal-title":"International Journal Of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaad.2004.07.011","article-title":"Tacrolimus ointment is effective for facial and intertriginous psoriasis","volume":"51","author":"Lebwohl","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0154|cit154","unstructured":"Lebwohl M Menter A Weiss J Clark SD Flores J Powers J Calcitriol 3 microg\/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies Journal of Drugs in Dermatology 2007 428 35"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0155|cit155","unstructured":"Lee J Youn J Kim N Kim K Kim T Choi J A randomized investigator-blinded comparative study of calcitriol twice a day vs. diflucortolone valerate morning plus calcitriol evening application in the treatment of mild to moderate psoriasis Journal of the European Academy of Dermatology & Venereology 2007 19"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0156|cit156","first-page":"571","article-title":"Double-Blind Comparison of Halcinonide Solution and Placebo Control in Treatment of Psoriasis of the Scalp","volume":"21","author":"Lepaw","year":"1978","journal-title":"Cutis"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaad.2009.10.016","article-title":"Pilot, multicenter, double-blind, randomized placebo-controlled bilateral comparative study of a combination of calcipotriene and nicotinamide for the treatment of psoriasis","volume":"63","author":"Levine","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaad.2009.10.016","article-title":"Pilot, multicenter, double-blind, randomized placebo-controlled bilateral comparative study of a combination of calcipotriene and nicotinamide for the treatment of psoriasis","volume":"63","author":"Levine","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0159|cit159","doi-asserted-by":"crossref","unstructured":"Liao YH Chiu HC Tseng YS Tsai TF Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial British Journal of Dermatology 2007 1005 12","DOI":"10.1111\/j.1365-2133.2007.08201.x"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000098576","article-title":"The efficacy and safety of topically applied indigo naturalis ointment in patients with plaque-type psoriasis","volume":"214","author":"Lin","year":"2007","journal-title":"Dermatology"},{"issue":"11","key":"10.1002\/14651858.CD005028.pub3-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archderm.144.11.1457","article-title":"Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis","volume":"144","author":"Lin","year":"2008","journal-title":"Archives of Dermatology"},{"issue":"Suppl 50","key":"10.1002\/14651858.CD005028.pub3-BIB0162|cit162","first-page":"17","article-title":"Can dithranol have a lasting effect and be more acceptable to patients? Micanol Cream - a trial of 171 patients with psoriasis","volume":"137","author":"Lister","year":"1997","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0163|cit163","doi-asserted-by":"crossref","unstructured":"Lowe N Feldman SR Sherer D Weiss J Shavin JS Lin YL Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis Journal of Dermatological Treatment 2005 158 64","DOI":"10.1080\/09546630510041060"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005028.pub3-BIB0164|cit164","first-page":"546","article-title":"Xamiol, a new treatment in scalp psoriasis: short- and long-term results","volume":"136","author":"Cambazard","year":"2009","journal-title":"Annales de Dermatologie et de Venereologie"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0165|cit165","doi-asserted-by":"crossref","unstructured":"Luger T Kidson P Cambazard F Larsen FG A 1-year, randomized, double-blind safety study of long-term treatment of a new gel formulation containing calcipotriene plus betamethasone dipropionate in scalp psoriasis Journal of the American Academy of Dermatology 2008 AB134","DOI":"10.1016\/j.jaad.2007.10.593"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0166|cit166","doi-asserted-by":"crossref","unstructured":"Luger TA Cambazard F Larsen FG Bourcier M Gupta G Clonier F A Study of the Safety and Efficacy of Calcipotriol and Betamethasone Dipropionate Scalp Formulation in the Long-Term Management of Scalp Psoriasis Dermatology 2008 321 8","DOI":"10.1159\/000155642"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0167|cit167","first-page":"794","article-title":"Prospective, randomized controlled double-blind study on the efficacy and safety of a series of herbal skin-care products for stable chronic plaque psoriasis [Abstract P061] European Congress on Psoriasis 2004","volume":"18","author":"Maier","year":"2004","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0168|cit168","first-page":"94","article-title":"Clinical Investigations of Mometasone Furoate - a Novel Nonfluorinated, Topical Corticosteroid","volume":"6","author":"Medansky","year":"1987","journal-title":"Seminars In Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0169|cit169","first-page":"20","article-title":"The Comparative Efficacy of Diflorasone Diacetate Ointment 0.05% (Psorcon\u00ae) vs Calcipotriene Ointment (Dovonex\u00ae) in the Treatment of Psoriasis","volume":"4","author":"Medansky","year":"1996","journal-title":"Journal of Geriatric Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0170|cit170","first-page":"52","article-title":"Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis","volume":"8","author":"Menter","year":"2009","journal-title":"Journal of Drugs in Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0171|cit171","doi-asserted-by":"crossref","unstructured":"Menter A Colon L Johnson L Gottschalk R Results from a randomized study comparing clobetasol propionate 0.05% spray to calcipotriene 0.005%, betamethasone dipropionate 0.064% ointment for the treatment of plaque psoriasis Journal of the American Academy of Dermatology 2008 AB124","DOI":"10.1016\/j.jaad.2007.10.550"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005028.pub3-BIB0173|cit172","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/0926-9959(95)96119-S","article-title":"Calcipotriol cream and betamethasone valerate cream of equal efficacy in psoriasis","volume":"5","author":"Molin","year":"1995","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0174|cit173","first-page":"110","article-title":"Comparative Efficacy of Calcipotriol Cream and Betamethasone Valerate Cream in the Treatment of Psoriasis","volume":"1","author":"Molin","year":"1996","journal-title":"Journal of Investigative Dermatology. Symposium Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0172|cit174","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2133.1997.tb08752.x","article-title":"Comparative Efficacy of Calcipotriol (Mc903) Cream and Betamethasone 17-Valerate Cream in the Treatment of Chronic Plaque Psoriasis. A Randomized, Double-Blind, Parallel Group Multicentre Study. Calcipotriol Study Group","volume":"136","author":"Molin","year":"1997","journal-title":"British Journal Of Dermatology"},{"issue":"11","key":"10.1002\/14651858.CD005028.pub3-BIB0175|cit175","first-page":"626","article-title":"Calcipotriol vs. Anthralin in the treatment of chronic plaque psoriasis","volume":"75","author":"Monastirli","year":"2000","journal-title":"H+G Zeitschrift Fur Hautkrankheiten."},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2340\/000155557296299","article-title":"Treatment of Psoriasis Vulgaris with Topical Calcipotriol Has No Short-Term Effect on Calcium or Bone Metabolism. A Randomized, Double-Blind, Placebo-Controlled Study","volume":"73","author":"Mortensen","year":"1993","journal-title":"Acta Dermato Venereologica"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0190-9622(91)70069-E","article-title":"A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis","volume":"24","author":"Olsen","year":"1991","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD005028.pub3-BIB0178|cit178","first-page":"57","article-title":"Efficacy and Safety of Fluticasone Propionate 0.005% Ointment in the Treatment of Psoriasis","volume":"57","author":"Olsen","year":"1996","journal-title":"Cutis"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0179|cit179","first-page":"57","article-title":"Efficacy and Safety of Fluticasone Propionate 0.005% Ointment in the Treatment of Psoriasis","volume":"2 Suppl","author":"Olsen","year":"1996","journal-title":"Cutis"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD005028.pub3-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0190-9622(97)70281-0","article-title":"Topical calcipotriol in childhood psoriasis","volume":"36","author":"Oranje","year":"1997","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0190-9622(97)70211-1","article-title":"A comparison of subjective and objective measures of reduction of psoriasis with the use of ultrasound, reflectance colorimetry, computerized video image analysis, and nitric oxide production","volume":"37","author":"Ormerod","year":"1997","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1046\/j.1365-2133.2000.03483.x","article-title":"Treatment of psoriasis with topical NG-monomethyl-L-arginine, an inhibitor of nitric oxide synthesis","volume":"142","author":"Ormerod","year":"2000","journal-title":"British Journal Of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2133.2005.06438.x","article-title":"Treatment of psoriasis with topical sirolimus: preclinical development and a randomized, double-blind trial","volume":"152","author":"Ormerod","year":"2005","journal-title":"British Journal of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD005028.pub3-BIB0184|cit184","first-page":"746","article-title":"Psoriasis: new Therapeutic Modality by Calcipotriol and Betamethasone Dipropionate","volume":"13","author":"Ortonne","year":"1994","journal-title":"Nouvelles Dermatologiques"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0185|cit185","unstructured":"Nicolas JF Calcitriol vs calcipotriol in psoriasis of sensitive areas [Abstract] 20th World Congress of Dermatology 1-5 July 2002, Paris Paris 2002 SA1048"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1365-2133.2003.05228.x","article-title":"Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas","volume":"148","author":"Ortonne","year":"2003","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000080854","article-title":"Efficacy of treatment with calcipotriol\/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: A randomised, double-blind trial","volume":"209","author":"Ortonne","year":"2004","journal-title":"Dermatology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005028.pub3-BIB0188|cit188","first-page":"374","article-title":"Calcipotriol\/betamethasone dipropionate ointment once daily versus tacalcitol once daily in psoriasis vulgaris [Abstract P27-49.] 12th Congress of the European Academy of Dermatology and Venereology. 15-18 October 2003, Barcelona, Spain","volume":"17","author":"Ortonne","year":"2003","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0189|cit189","doi-asserted-by":"crossref","unstructured":"Ortonne JP van de Kerkhof PCM Prinz JC Bieber T Lahfa M Rubins A 0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study Acta Dermato-Venereologica 2006 29 33","DOI":"10.1080\/00015550510039817"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2133.2008.08442.x","article-title":"Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression","volume":"158","author":"Vissers","year":"2008","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0191|cit191","first-page":"585","article-title":"Comparison of two different dose combinations of calcipotriol\/hydrocortisone ointment used once daily for the treatment of psoriasis vulgaris on the face and body","volume":"20","author":"Ortonne","year":"2010","journal-title":"European Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/09546630510043202","article-title":"Efficacy of 2 weeks' application of theophylline ointment in psoriasis vulgaris","volume":"16","author":"Papakostantinou","year":"2005","journal-title":"Journal of Dermatological Treatment"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mjd.2003.130","article-title":"Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis","volume":"48","author":"Papp","year":"2003","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mjd.2003.130","article-title":"Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis","volume":"48","author":"Papp","year":"2003","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD005028.pub3-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/archderm.1996.03890360121033","article-title":"Calcipotriene ointment applied once a day for psoriasis: A double- blind, multicenter, placebo-controlled study","volume":"132","author":"Pariser","year":"1996","journal-title":"Archives of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/09546630410023566","article-title":"Fluocinolone acetonide topical oil for scalp psoriasis","volume":"15","author":"Pauporte","year":"2004","journal-title":"Journal of Dermatological Treatment"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2133.1996.tb07608.x","article-title":"Efficacy and Safety of Topical Calcitriol (1,25-Dihydroxyvitamin D3) for the Treatment of Psoriasis","volume":"134","author":"Perez","year":"1996","journal-title":"British Journal Of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0198|cit198","first-page":"16","article-title":"Comparative Effects of Calcipotriol Ointment (50 Micrograms\/G) and 5% Coal Tar\/2% Allantoin\/0.5% Hydrocortisone Cream in Treating Plaque Psoriasis","volume":"51","author":"Pinheiro","year":"1997","journal-title":"British Journal of Clinical Practice"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/09546630903493311","article-title":"Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis","volume":"21","author":"Poulin","year":"2010","journal-title":"Journal of Dermatological Treatment"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0200|cit200","first-page":"43","article-title":"Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis","volume":"85","author":"Poulin","year":"2010","journal-title":"Cutis"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0201|cit201","doi-asserted-by":"crossref","unstructured":"Poulin Y Papp K Guenther L Bissonnette R Twice-weekly use of clobetasol propionate 0.05% shampoo is effective and safe for the long-term control of scalp psoriasis Journal of the American Academy of Dermatology 2010 AB132","DOI":"10.1016\/j.jaad.2009.11.508"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0203|cit202","unstructured":"Powers J Assessment of the Efficacy and Safety of Calcitriol 3mcg\/g Ointment in the Treatment of Chronic Plaque Psoriasis 7th Asian Congress of Dermatology incorporating the 5th Regional Conference of Paediatric Dermatology Kuala Lumpur, Malaysia 28 September -1 October, 2005 2005 367"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0202|cit203","unstructured":"Powers J Balin AK Kempers S Glinert RJ Fleming T Graeber M Assessment of the efficacy and safety of calcitriol 3ugg-1 ointment in the treatment of chronic plaque psoriasis [Abstract P-40.] 85th BAD Annual Meeting 5-8 July 2005, Glasgow, UK British Journal of Dermatology 2005 32"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0204|cit204","doi-asserted-by":"crossref","unstructured":"Reygagne P Mrowietz U Decroix J De Waard-Van Der Spek FB Acebes LO Figueiredo A Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: A randomized comparison of efficacy and safety in subjects with scalp psoriasis Journal of Dermatological Treatment 2005 31 6","DOI":"10.1080\/09546630410024853"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0205|cit205","unstructured":"Reygagne P Mrowietz U Decroix J Van der Spek W Olmos Acebes L Figueiredo A Four-week efficacy and safety comparison of a new clobetasol shampoo and calcipotriol solution 0.005% in subjects with scalp psoriasis 11th Congress of the European Academy of Dermatology & Venereology, 2-6 October, 2002, Prague 2002 27 36"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0206|cit206","first-page":"107","article-title":"Clinical Efficacy of a Monotherapy with Calcipotriol-Ointment Compared to Combination Therapy with Calcipotriol Ointment and Betamethasone Valerate Ointment in Psoriasis Vulgaris","volume":"1","author":"Ruzicka","year":"1996","journal-title":"Journal of Investigative Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1365-2133.1998.02070.x","article-title":"Comparison of Calcipotriol Monotherapy and a Combination of Calcipotriol and Betamethasone Valerate after 2 Weeks' Treatment with Calcipotriol in the Topical Therapy of Psoriasis Vulgaris: A Multicentre, Double-Blind, Randomized Study","volume":"138","author":"Ruzicka","year":"1998","journal-title":"British Journal Of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/00015550050500022","article-title":"Double-blind, placebo-controlled, randomized, right-left study comparing calcipotriol monotherapy with a combined treatment of calcipotriol and diflucortolone valerate in chronic plaque psoriasis","volume":"Suppl 211","author":"Salmhofer","year":"2000","journal-title":"Acta Dermato Venereologica"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0209|cit209","first-page":"174","article-title":"Treatment of plague-type psoriasis with topical propylthiouracil","volume":"92","author":"Sanchez","year":"2001","journal-title":"Actas Dermo Sifiliograficas"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0210|cit210","first-page":"77","article-title":"Short-term clinical efficacy of the association betamethasone 17-valerate 21-acetate + tretinoine + salicylic acid in outpatients affected with disseminated keratotic plaque psoriasis: A double blinded placebo-controlled multicentric randomized clinical trial","volume":"136","author":"Santoianni","year":"2001","journal-title":"Giornale Italiano di Dermatologia e Venereologia"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0211|cit211","doi-asserted-by":"crossref","unstructured":"Saraceno R Andreassi L Ayala F Bongiorno MR Giannetti A Lisi P Efficacy, safety and quality of life of calcipotriol\/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial Journal of Dermatological Treatment 2007 361 5","DOI":"10.1080\/09546630701646156"},{"issue":"Suppl","key":"10.1002\/14651858.CD005028.pub3-BIB0212|cit212","first-page":"47","article-title":"Calcipotriol: Clinical Trial Versus Betamethasone Dipropionate + Salicylic Acid","volume":"186","author":"Scarpa","year":"1994","journal-title":"Acta Dermato Venereologica"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0214|cit213","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1468-3083.1996.tb00157.x","article-title":"Tacalcitol Ointment Is an Efficacious and Well Tolerated Treatment for Psoriasis","volume":"6","author":"Scarpa","year":"1996","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0213|cit214","first-page":"110","article-title":"Efficacy and Tolerability of Tacalcitol Ointment on Psoriatic Skin: Study in 63 Patients","volume":"1","author":"Scarpa","year":"1996","journal-title":"Journal of Investigative Dermatology. Symposium Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0215|cit215","first-page":"335","article-title":"Efficacy and Tolerability of Tacalcitol Administered Once Daily in the Treatment of Psoriasis Vulgaris (Double-Blind, Randomized, Placebo Controlled Italian Multicenter Study)","volume":"132","author":"Scarpa","year":"1997","journal-title":"Giornale Italiano di Dermatologia e Venereologia"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0216|cit216","first-page":"140","article-title":"A Double-Blind, Randomized, Placebo-Controlled Evaluation of the Efficacy and Safety of Hydrocortisone Buteprate 0.1% Cream in the Treatment of Psoriasis","volume":"14","author":"Sears","year":"1997","journal-title":"Advances In Therapy"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000211459","article-title":"Assessment of the Activity of Tacalcitol on Psoriatic Plaques by Means of Colorimetry and High-Frequency Ultrasound: A Double-Blind Intrasubject Half-Side Right-Left Comparison with Betamethasone Valerate and Placebo","volume":"10","author":"Seidenari","year":"1997","journal-title":"Skin Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000211459","article-title":"Assessment of the Activity of Tacalcitol on Psoriatic Plaques by Means of Colorimetry and High-Frequency Ultrasound: A Double-Blind Intrasubject Half-Side Right-Left Comparison with Betamethasone Valerate and Placebo","volume":"10","author":"Seidenari","year":"1997","journal-title":"Skin Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/09546639809160548","article-title":"A double-blind, placebo-controlled study of the clinical efficacy of ciclopirox olamine (1.5%) shampoo for the control of scalp psoriasis","volume":"9","author":"Shuttleworth","year":"1998","journal-title":"Journal Of Dermatological Treatment"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0220|cit220","first-page":"147","article-title":"Efficacy of Topical Treatment in Psoriasis with Mc903, a New Vitamin D Analogue","volume":"69","author":"Staberg","year":"1989","journal-title":"Acta Dermato Venereologica"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/120347540100500404","article-title":"Betamethasone valerate foam for treatment of nonscalp psoriasis","volume":"5","author":"Stein","year":"2001","journal-title":"Journal of Cutaneous Medicine & Surgery"},{"issue":"76","key":"10.1002\/14651858.CD005028.pub3-BIB0222|cit222","first-page":"S12","article-title":"Topical treatment of chronic-stationary plaque psoriasis with vitamin B12","volume":"Suppl 1","author":"Hoffmann","year":"2001","journal-title":"Zeitschrift Fur Hautkrankheiten"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000051729","article-title":"Vitamin B(12) cream containing avocado oil in the therapy of plaque psoriasis","volume":"203","author":"Stuecker","year":"2001","journal-title":"Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archderm.1996.03890260135023","article-title":"Failure of topical polymyxin B to improve mild plaque psoriasis [letter]","volume":"132","author":"Stutz","year":"1996","journal-title":"Archives of Dermatology"},{"issue":"9","key":"10.1002\/14651858.CD005028.pub3-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-4362.1981.tb00847.x","article-title":"A Comparison of Single and Multiple Applications of Halcinonide Cream","volume":"20","author":"Sudilovsky","year":"1981","journal-title":"International Journal Of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD005028.pub3-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1365-4362.2001.01244.x","article-title":"A clinical study to determine the efficacy and safety of 1% methotrexate\/Azone (MAZ) gel applied topically once daily in patients with psoriasis vulgaris","volume":"40","author":"Sutton","year":"2001","journal-title":"International Journal Of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1365-3156.1996.d01-91.x","article-title":"Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-controlled, double-blind study","volume":"1","author":"Syed","year":"1996","journal-title":"Tropical Medicine & International Health"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/120347540100500403","article-title":"Management of psoriasis vulgaris with methotrexate 0.25% in a hydrophilic gel: a placebo-controlled, double-blind study","volume":"5","author":"Syed","year":"2001","journal-title":"Journal of Cutaneous Medicine & Surgery"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2133.1994.tb04981.x","article-title":"A comparative study of calcipotriol ointment and tar in chronic plaque psoriasis","volume":"131","author":"Tham","year":"1994","journal-title":"British Journal Of Dermatology"},{"issue":"11","key":"10.1002\/14651858.CD005028.pub3-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1365-4632.2010.04598.x","article-title":"A calcipotriene\/betamethasone dipropionate two-compound scalp formulation in the treatment of scalp psoriasis in Hispanic\/Latino and Black\/African American patients: Results of the randomized, 8-week, double-blind phase of a clinical trial","volume":"49","author":"Tyring","year":"2010","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0231|cit231","doi-asserted-by":"crossref","unstructured":"Tzung TY Wu JC Hsu NJ Chen YH Ger LP Comparison of tazarotene 0.1% gel plus petrolatum once daily versus calcipotriol 0.005% ointment twice daily in the treatment of plaque psoriasis Acta Dermato Venereologica 2005 236 9","DOI":"10.1080\/00015550510027405"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0232|cit232","doi-asserted-by":"crossref","unstructured":"Vali A Asilian A Khalesi E Khoddami L Shahtalebi M Mohammady M Evaluation of the efficacy of topical caffeine in the treatment of psoriasis vulgaris Journal of Dermatological Treatment 2005 234 7","DOI":"10.1080\/09546630510011801"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0233|cit233","doi-asserted-by":"crossref","unstructured":"Vali A Asilian A Khalesi E Khoddami L Shahtalebi M Mohammady M Evaluation of the efficacy of topical caffeine in the treatment of psoriasis vulgaris: A randomized, double-blind clinical trial [Abstract] Iranian Journal of Dermatology 2006 87","DOI":"10.1080\/09546630510011801"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0234|cit234","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2133.1989.tb01353.x","article-title":"A Double-Blind Study of Topical 1 Alpha,25-Dihydroxyvitamin D3 in Psoriasis","volume":"120","author":"Kerkhof","year":"1989","journal-title":"British Journal Of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2133.1996.tb03886.x","article-title":"Tacalcitol Ointment in the Treatment of Psoriasis Vulgaris: A Multicentre, Placebo- Controlled, Double- Blind Study on Efficacy and Safety","volume":"135","author":"Kerkhof","year":"1996","journal-title":"British Journal Of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000057884","article-title":"Safety and efficacy of combined high-dose treatment with calcipotriol ointment and solution in patients with psoriasis","volume":"204","author":"Kerkhof","year":"2002","journal-title":"Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0237|cit237","doi-asserted-by":"crossref","unstructured":"De Korte J van der Valk PG Sprangers MA Damstra RJ Kunkeler AC Lijnen RL A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting British Journal of Dermatology 2008 375 81","DOI":"10.1111\/j.1365-2133.2007.08337.x"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0238|cit238","doi-asserted-by":"crossref","unstructured":"Van de Kerkhof PC van der Valk PG Swinkels OQ Kucharekova M de Rie MA de Vries HJ A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting British Journal of Dermatology 2006 800 7","DOI":"10.1111\/j.1365-2133.2006.07393.x"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0239|cit239","first-page":"AB182","article-title":"A new scalp formulation of calcipotriene plus betamethasone in the treatment of scalp psoriasis compared to its active ingredients in the same vehicle [Abstract P2734.] American Academy of Dermatology 65th Annual Meeting 2-6 February, 2007","volume":"56","author":"Kerkhof","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0240|cit240","doi-asserted-by":"crossref","unstructured":"Van de Kerkhof PCM Hoffmann V Anstey A Barnes L Bolduc C Reich K A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial British Journal of Dermatology 2009 170 6","DOI":"10.1111\/j.1365-2133.2008.08927.x"},{"issue":"7","key":"10.1002\/14651858.CD005028.pub3-BIB0241|cit241","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/00007611-197607000-00017","article-title":"Betamethasone Dipropionate Ointment in the Treatment of Psoriasis and Atopic Dermatitis: A Double-Blind Study","volume":"69","author":"Vanderploeg","year":"1976","journal-title":"Southern Medical Journal"},{"issue":"8","key":"10.1002\/14651858.CD005028.pub3-BIB0242|cit242","first-page":"676","article-title":"In-Patient Treatment with Calcipotriol Versus Dithranol in Refractory Psoriasis","volume":"5","author":"Vleuten","year":"1995","journal-title":"European Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2133.1997.tb03790.x","article-title":"Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial","volume":"137","author":"Veien","year":"1997","journal-title":"British Journal Of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0244|cit244","unstructured":"Vladimirov VV Tcherjomukchina IJ Kurjanova ON Menshikova LV Mazina NM Efficacy of calcipotriol ointment compared to betamethasone 17-valerate ointment in the treatment of psoriasis [Abstract] Skin Therapy Update '94 Crete, Greece 1994 219"},{"issue":"Suppl","key":"10.1002\/14651858.CD005028.pub3-BIB0245|cit245","first-page":"20","article-title":"Short-Contact Treatment at Home with Micanol","volume":"172","author":"Volden","year":"1992","journal-title":"Acta Dermato Venereologica"},{"issue":"Suppl 50","key":"10.1002\/14651858.CD005028.pub3-BIB0246|cit246","first-page":"55","article-title":"Psoriasis; the Burden of Disease Before, During and After Treatment with Dovonex Ointment or Dithrocream","volume":"137","author":"Wall","year":"1997","journal-title":"British Journal Of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0247|cit247","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1046\/j.1365-2133.1998.02556.x","article-title":"A comparison of treatment with dithranol and calcipotriol on the clinical severity and quality of life in patients with psoriasis","volume":"139","author":"Wall","year":"1998","journal-title":"British Journal Of Dermatology"},{"issue":"Suppl 49","key":"10.1002\/14651858.CD005028.pub3-BIB0249|cit248","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2133.1996.tb15664.x","article-title":"Safety, Efficacy and Duration of Therapeutic Effect of Tazarotene Used in the Treatment of Plaque Psoriasis","volume":"135","author":"Weinstein","year":"1996","journal-title":"British Journal Of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0248|cit249","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0190-9622(97)70216-0","article-title":"Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect","volume":"37","author":"Weinstein","year":"1997","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0251|cit250","unstructured":"Weinstein GD Tazarotene cream in the treatment of plaque psoriasis [Abstract] 20th World Congress of Dermatology, 1-5 July 2002, Paris 2002 P2043"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0250|cit251","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1067\/mjd.2003.103","article-title":"Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks","volume":"48","author":"Weinstein","year":"2003","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0252|cit252","doi-asserted-by":"crossref","unstructured":"White S Vender R Thaci D Haverkamp C Naeyaert J-M Foster R Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene\/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial American Journal of Clinical Dermatology 2006 177 84","DOI":"10.2165\/00128071-200607030-00004"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0253|cit253","doi-asserted-by":"crossref","unstructured":"White S Vender R Thaci D Haverkamp C Naeyaert J-M Foster R Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene\/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial American Journal of Clinical Dermatology 2006 177 84","DOI":"10.2165\/00128071-200607030-00004"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0254|cit254","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/09546639509080590","article-title":"Clinical evaluation of a PAF-antagonist in psoriasis vulgaris","volume":"6","author":"Wolska","year":"1995","journal-title":"Journal Of Dermatological Treatment"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0255|cit255","first-page":"23","article-title":"A new corticosteroid for moderate\/severe dermatoses","volume":"82","author":"Wortzel","year":"1975","journal-title":"Clinical Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0256|cit256","first-page":"23","article-title":"A new corticosteroid for moderate\/severe dermatoses","volume":"82","author":"Wortzel","year":"1975","journal-title":"Clinical Medicine"},{"issue":"7-8","key":"10.1002\/14651858.CD005028.pub3-BIB0257|cit257","first-page":"482","article-title":"Treatment of chronic-stationary psoriasis with fluocinolone acetonide and calcipotriol","volume":"76","author":"Wozel","year":"2001","journal-title":"Zeitschrift Fur Hautkrankheiten"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0258|cit258","first-page":"401","article-title":"Clinical observation of sequential therapy of calcipotriol cream with halometasone cream in plaque type psoriasis","volume":"38","author":"Yang","year":"2009","journal-title":"Journal of Clinical Dermatology"},{"issue":"9","key":"10.1002\/14651858.CD005028.pub3-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archderm.134.9.1101","article-title":"Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study","volume":"134","author":"Zonneveld","year":"1998","journal-title":"Archives of Dermatology"},{"issue":"9","key":"10.1002\/14651858.CD005028.pub3-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archderm.134.9.1101","article-title":"Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study","volume":"134","author":"Zonneveld","year":"1998","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0261|cit261","doi-asserted-by":"crossref","unstructured":"Agrawal Y Petkar KC Sawant KK Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis International Journal of Pharmaceutics 2010 93 102","DOI":"10.1016\/j.ijpharm.2010.09.007"},{"issue":"Suppl. 1","key":"10.1002\/14651858.CD005028.pub3-BIB0262|cit262","first-page":"S50","article-title":"Topical Ammonium-trichlorotellurate (AS101) in the treatment of mild plaque-type psoriasis; double-blind placebo controlled study","volume":"129","author":"Akerman","year":"2009","journal-title":"Journal of Investigative Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0263|cit263","first-page":"237","article-title":"Clinical evaluation of the scalp psoriasis treatment with clobetasol propionate 0.05% lotion","volume":"89","author":"Ambroziak","year":"2002","journal-title":"Przeglad Dermatologiczny"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0264|cit264","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/09546639509097171","article-title":"Optimal concentration of tacalcitol in once-daily treatment of psoriasis","volume":"6","author":"Baadsgaard","year":"1995","journal-title":"Journal Of Dermatological Treatment"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/09546639909056030","article-title":"Topical treatment of nail psoriasis with a new corticoid-containing nail lacquer formulation","volume":"10","author":"Baran","year":"1999","journal-title":"Journal Of Dermatological Treatment"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0266|cit266","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2133.2003.05392.x","article-title":"Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study","volume":"149","author":"Bianchi","year":"2003","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0267|cit267","doi-asserted-by":"crossref","unstructured":"Brodell R Goffe BS Weiss JS Bruce S Safety and efficacy of two regimens involving clobetasol spray, 0.05% and calcitriol ointment, 3 mug\/g for moderate plaque psoriasis Journal of the American Academy of Dermatology 2011 AB149","DOI":"10.1016\/j.jaad.2010.09.609"},{"issue":"12","key":"10.1002\/14651858.CD005028.pub3-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"814","DOI":"10.5414\/CPP48814","article-title":"Evaluation of methylprednisolone aceponate, tacrolimus and combination thereof in the psoriasis plaque test using sum score, 20-MHz-ultrasonography and optical coherence tomography","volume":"48","author":"Buder","year":"2010","journal-title":"International Journal of Clinical Pharmacology & Therapeutics"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD005028.pub3-BIB0269|cit269","first-page":"45","article-title":"Comparison of Safety and Efficacy of Fluticasone Propionate Cream, 0.05%, and Betamethasone Valerate Cream, 0.1%, in the Treatment of Moderate-to-Severe Psoriasis","volume":"57","author":"Callen","year":"1996","journal-title":"Cutis"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0270|cit270","doi-asserted-by":"crossref","unstructured":"Cannavo SP Guarneri F Vaccaro M Borgia F Guarneri B Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study Dermatology 2003 153 6 12592084","DOI":"10.1159\/000068469"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0271|cit271","unstructured":"Cannavo SP Guarneri F Vaccaro M Borgia FAD Institute of Dermatology University of Messina Italy Treatment of psoriatic nails with topical cyclosporin 11th Congress of the European Academy of Dermatology and Venereology 2002 P27 89"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archderm.141.1.43","article-title":"Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment","volume":"141","author":"Carroll","year":"2005","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000018281","article-title":"Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study","volume":"199","author":"Jong","year":"1999","journal-title":"Dermatology"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD005028.pub3-BIB0274|cit274","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0190-9622(94)70210-1","article-title":"A controlled trial of topical propylthiouracil in the treatment of patients with psoriasis","volume":"31","author":"Elias","year":"1994","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0275|cit275","doi-asserted-by":"crossref","unstructured":"Esposito M The therapeutic advantages on BMV plaster in chronic plaque psoriasis. Results from a new European multicentric study Annales de Dermatologie et de Venereologie 2009 S476 80","DOI":"10.1016\/S0151-9638(09)73615-4"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0276|cit276","unstructured":"Friedrich M Vollhardt K Zahlten R Sterry W Wolff G Demonstration of antipsoriatic efficacy of a new topical formulation of the small molecule selectin antagonist bimosiamose [Abstract P016]. European Congress on Psoriasis 2004 Journal of the European Academy of Dermatology & Venereology 2004 779"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD005028.pub3-BIB0277|cit277","first-page":"AB138","article-title":"In vitro activity and safety assessment of a novel calcipotriene foam formulation. 68th Annual Meeting of the American Academy of Dermatology, Miami, FL United States","volume":"62","author":"Hsia","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0278|cit278","doi-asserted-by":"crossref","unstructured":"Insa R de la Cruz G Gassmueller J Leon M Topical cyclosporin proves efficacy in psoriatic patients in a phase I\/II clinical trial. 67th Annual Meeting of the American Academy of Dermatology, San Francisco, CA United States Journal of the American Academy of Dermatology 2009 AB180","DOI":"10.1016\/j.jaad.2008.11.780"},{"issue":"8","key":"10.1002\/14651858.CD005028.pub3-BIB0279|cit279","first-page":"964","article-title":"Efficacy of 15% azelaic acid in psoriasis vulgaris: a randomized, controlled clinical trial","volume":"9","author":"Iraji","year":"2010","journal-title":"Journal of Drugs in Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0280|cit280","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2336\/nishinihonhifu.67.522","article-title":"A comparative study of maxacalcitol monotherapy, clobetasol propionate monotherapy and the combination of each agent as a premixed ointment for the treatment of psoriasis. [Japanese]","volume":"67","author":"Ito","year":"2005","journal-title":"Nishinihon Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0281|cit281","first-page":"483","article-title":"A Clinical Trial of Lonapalene Fluocinolone Acetonide and Vehicle in Psoriasis [Abstract]","volume":"86","author":"Jansen","year":"1986","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0282|cit282","unstructured":"Kaur I Jain R Kumar B Comparative study of calcipotriol (0.005%) vs tazarotene (0.05%, 0.1%) in stable plaque psoriasis [Abstract P015]. European Congress on Psoriasis 2004 Journal of the European Academy of Dermatology & Venereology 2004 779"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005028.pub3-BIB0283|cit283","first-page":"33","article-title":"The efficacy of 0.1% tacrolimus ointment compared with clobetasone butyrate 0.05% ointment in patients with facial, flexural or genital psoriasis [Abstract P-41]. The 85th BAD Annual Meeting 5-8th July 2005, Glasgow, UK","volume":"153","author":"Kleyn","year":"2005","journal-title":"British Journal of Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD005028.pub3-BIB0284|cit284","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/archderm.1989.01670240047011","article-title":"Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903)","volume":"125","author":"Kragballe","year":"1989","journal-title":"Archives of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0285|cit285","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2340\/0001555574398402","article-title":"Efficacy and Safety of the 20-Epi-Vitamin D3 Analogue Kh 1060 in the Topical Therapy of Psoriasis: Results of a Dose-Ranging Study","volume":"74","author":"Kragballe","year":"1994","journal-title":"Acta Dermato-Venereologica"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0286|cit286","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0190-9622(98)70323-8","article-title":"Calcipotriene Ointment and Halobetasol Ointment in the Long-Term Treatment of Psoriasis: Effects on the Duration of Improvement","volume":"39","author":"Lebwohl","year":"1998","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0287|cit287","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-4362.2001.01067-7.x","article-title":"Duration of improvement in psoriasis after treatment with tazarotene 0.1% gel plus clobetasol propionate 0.05% ointment: comparison of maintenance treatments","volume":"40","author":"Lebwohl","year":"2001","journal-title":"International Journal Of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0288|cit288","first-page":"201","article-title":"The safety of topical cyclosporin A conjugate (CGC1072) in the treatment of mild to moderate psoriasis [Abstract 1201] International Investigative Dermatology. The 4th Joint Meeting of the ESDR, Japanese SID & SID, 30th April-4th May 2003, Florida, USA","volume":"121","author":"Levin","year":"2003","journal-title":"Journal of Investigative Dermatology"},{"issue":"20","key":"10.1002\/14651858.CD005028.pub3-BIB0289|cit289","first-page":"1218","article-title":"Daivonex registered trade mark ointment twice a day versus Daivonex registered trade mark cream in the morning and Daivonex registered trade mark ointment in the evening","volume":"86","author":"Meyrat","year":"1996","journal-title":"Ars Medici"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005028.pub3-BIB0290|cit290","first-page":"165","article-title":"A double blind aleatory and prospective study of topical vitamin b12 in psoriasis [Abstract P06.21]. The 14th Congress of the European Academy of Dermatology and Venereology, London, UK. 12-15th October 2005","volume":"19","author":"Palazon","year":"2005","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0291|cit291","unstructured":"Reygagne P Diaconu J Pr\u00e8s H Ernst TM Meyer KG S.A.D.A Efficacy and safety comparison of clobetasol propionate shampoo, gel and vehicle in scalp psoriasis 11th Congress of the European Academy of Dermatology and Venereology 2002 P27 9"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD005028.pub3-BIB0292|cit292","first-page":"AB210","article-title":"A double-blind, placebo-controlled study of a natural topical anti-inflammatory for treatment of atopic dermatitis and psoriasis [Abstract P2849]. American Academy of Dermatology 64th Annual Meeting March 3-7, 2006","volume":"54","author":"Rhemus","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0293|cit293","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00105-003-0655-6","article-title":"Treatment of scalp psoriasis. An effective and safe tacalcitol emulsion","volume":"55","author":"Ruzicka","year":"2004","journal-title":"Hautarzt"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0294|cit294","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s001050050743","article-title":"Mometasone and calcipotriol optimise the initial therapeutic effect of dithranol on chronic plaque psoriasis","volume":"49","author":"Sander","year":"1998","journal-title":"Hautarzt"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0295|cit295","doi-asserted-by":"crossref","unstructured":"Saraswat A Agarwal R Katare OP Kaur I Kumar B A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis Journal of Dermatological Treatment 2007 40 5","DOI":"10.1080\/09546630601028729"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0296|cit296","unstructured":"Scher R Tazarotene 0.1% gel in the treatment of nail psoriasis [Abstract] 20th World Congress of Dermatology, 1st to 5th July 2002 2002 P0791"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0297|cit297","first-page":"355","article-title":"Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study","volume":"68","author":"Scher","year":"2001","journal-title":"Cutis"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0298|cit298","first-page":"170","article-title":"Treating fingernail psoriasis with tazarotene 0.1% gel: A vehicle-controlled study [Abstract]. 2nd Joint Meeting International Psoriasis Symposium and European Congress on Psoriasis","volume":"14","author":"Scher","year":"2001","journal-title":"Skin Pharmacology & Applied Skin Physiology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0299|cit299","first-page":"282","article-title":"Clinical Evaluation of Hydrocortisone Valerate 0.2% Ointment","volume":"6","author":"Sefton","year":"1984","journal-title":"Clinical Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD005028.pub3-BIB0300|cit300","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1046\/j.1365-4362.2003.01974.x","article-title":"Calcipotriol versus coal tar: a prospective randomized study in stable plaque psoriasis","volume":"42","author":"Sharma","year":"2003","journal-title":"International Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0301|cit301","first-page":"167","article-title":"Management of psoriasis of the scalp with methotrexate (0.25%) in an aerosolized spray gel. A placebo-controlled, double-blind study [Abstract]. 2nd Joint Meeting International Psoriasis Symposium and European Congress on Psoriasis","volume":"14","author":"Syed","year":"2001","journal-title":"Skin Pharmacology & Applied Skin Physiology"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0302|cit302","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2336\/nishinihonhifu.66.188","article-title":"Effectiveness of Combination between Diflucortolone Valerate and Vitamin D3 Analogue in the Treatment of Psoriasis Vulgaris. [Japanese]","volume":"66","author":"Tokura","year":"2004","journal-title":"Nishinihon Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0303|cit303","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2133.1998.02462.x","article-title":"Calcipotriol Ointment in Nail Psoriasis: A Controlled Double-Blind Comparison with Betamethasone Dipropionate and Salicylic Acid","volume":"139","author":"Tosti","year":"1998","journal-title":"British Journal Of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0304|cit304","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1365-2133.2003.05421.x","article-title":"Observer-blind, randomized, intrapatient comparison of a novel 1% coal tar preparation (Exorex) and calcipotriol cream in the treatment of plaque type psoriasis","volume":"149","author":"Tzaneva","year":"2003","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0305|cit305","unstructured":"van de Kerkhof PCM Kuypers A A randomised, double blind, left right study to compare hydrocortisone 17-butyrate 0.1% emulsion with vehicle in the treatment of patients suffering from psoriasis vulgaris [Poster P16] 6th International Skin Symposium Brussels 1996"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0306|cit306","doi-asserted-by":"crossref","unstructured":"Vena GA Cassano N Agnusdei CP Bellini M Calabretta S Centofanti S Treatment of psoriasis vulgaris with calcipotriol betamethasone dipropionate combination followed by calcipotriol and assessment of the adjuvant basic use of urea-based emollients European Journal of Inflammation 2005 37 41","DOI":"10.1177\/1721727X0500300108"},{"issue":"12","key":"10.1002\/14651858.CD005028.pub3-BIB0307|cit307","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/j.1468-3083.2011.04332.x","article-title":"Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial","volume":"26","author":"Bissonnette","year":"2012","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0308|cit308","unstructured":"NCT01098721 A Safety\/Efficacy Study of a Non-steroid, Topical Cream Treatment of Psoriasis Over 12-weeks (134993) clinicaltrials.gov\/ct2\/show\/NCT01098721 (accessed January 2013)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005028.pub3-BIB0309|cit309","first-page":"S44","article-title":"Novel mechanism for topical treatment of plaque psoriasis \u2013 results of a randomized, double blind, concentration ranging, vehicle controlled 12 week study with JAK 1\/2 inhibitor INCB018424 cream (Abstract 261). 2010 Annual Meeting of the Society for Investigative Dermatology, Hilton Atlanta, Atlanta, Georgia, May 5-8","volume":"130","author":"Callis Duffin","year":"2010","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0310|cit310","unstructured":"NCT00778700 A Dose Ranging Study of the Effect of INCB018424 Phosphate Cream When Applied to Patients With Plaque Psoriasis clinicaltrials.gov\/show\/NCT00778700 (accessed January 2013)"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0311|cit311","first-page":"295","article-title":"The separate daily application of tacalcitol 4 microg\/g ointment and budesonide 0.25 mg\/g cream is more effective than the single daily application of a two compound ointment containing calcipotriol 50 microg\/g and betamethasone dipropionate 0.5 mg\/g","volume":"146","author":"Calzavara-Pinton","year":"2011","journal-title":"Giornale Italiano di Dermatologia e Venereologia"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD005028.pub3-BIB0312|cit312","first-page":"AB156","article-title":"Bilateral comparison study on the order of application of combination clobetasol proprionate spray and calcitriol ointment in the treatment of plaque psoriasis. (Abstract P3343). Conference: 69th Annual Meeting of the American Academy of Dermatology New Orleans, LA United States. Conference Start: 20110204 Conference End: 20110208. Conference Publication","volume":"64","author":"Henry","year":"2011","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0313|cit313","first-page":"382","article-title":"Combination of calcipotriol and clobetasol propionate as a premixed ointment for the treatment of psoriasis","volume":"13","author":"Katoh","year":"2003","journal-title":"European Journal of Dermatology"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD005028.pub3-BIB0314|cit314","first-page":"AB157","article-title":"Safety and bioavailability of two calcipotriene formulations in subjects with mild to moderate plaque-type psoriasis. (Abstract P3348). Conference: 69th Annual Meeting of the American Academy of Dermatology New Orleans, LA United States. Conference Start: 20110204 Conference End: 20110208","volume":"64","author":"Matheson","year":"2011","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0315|cit315","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1468-3083.2004.01186.x","article-title":"A double-blind, placebo-controlled study of a commercial Aloe vera gel in the treatment of slight to moderate psoriasis vulgaris","volume":"19","author":"Paulsen","year":"2005","journal-title":"Journal Of The European Academy Of Dermatology & Venereology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0316|cit316","first-page":"187","article-title":"Treatment of localized psoriasis with a topical formulation of zinc pyrithione","volume":"20","author":"Sadeghian","year":"2011","journal-title":"Acta Dermatovenerologica Alpina, Panonica et Adriatica"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0317|cit317","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2133.2004.06037.x","article-title":"Inefficacy of topical thyroid hormone analogue TriAc in plaque psoriasis: results of a double-blind placebo-controlled trial","volume":"151","author":"Vahlquist","year":"2004","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0318|cit318","first-page":"425","article-title":"Comparison of the efficacy of tacalcitol ointment and 17 a hydrocortisone cream in the treatment of psoriasis (Chinese)","volume":"32","author":"Yang","year":"1999","journal-title":"Chinese Journal of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0319|cit319","unstructured":"NCT00824980 Combined Inhibition of Dipeptidyl Peptidase IV (DPIV\/CD26) and Aminopeptidase N (APN\/CD13) in the Treatment of Psoriasis clinicaltrials.gov\/ct2\/show\/NCT00824980 (accessed December 2011)"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0320|cit320","unstructured":"NCT01018134 Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study clinicaltrials.gov\/ct2\/show\/NCT01018134 (accessed December 2011)"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0321|cit321","unstructured":"NCT01206387 \u00a0 Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis clinicaltrials.gov\/ct2\/show\/NCT01206387 (accessed December 2011)"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0322|cit322","unstructured":"NCT01206660 Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis clinicaltrials.gov\/ct2\/show\/NCT01206660 (accessed December 2011)"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0323|cit323","unstructured":"NCT01246583 CP-690-550 Ointment For Chronic Plaque Psoriasis clinicaltrials.gov\/ct2\/show\/NCT01246583 (accessed December 2011)"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0324|cit324","unstructured":"NCT01247818 \u00a0 Randomized Study of PH-10 for Psoriasis clinicaltrials.gov\/ct2\/show\/NCT01247818 (accessed December 2011)"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0325|cit325","unstructured":"NCT01422434 LEO 90105 Ointment in Japanese Subjects With Psoriasis clinicaltrials.gov\/ct2\/show\/results\/NCT01422434 (accessed December 2011)"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0326|cit326","unstructured":"NCT01465282 Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris clinicaltrials.gov\/ct2\/show\/NCT01465282 (accessed December 2011)"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0327|cit327","unstructured":"NCT01536886 LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris clinicaltrials.gov\/show\/NCT01536886 (accessed August 2012)"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0328|cit328","unstructured":"NCT01536938 LEO 90100 in the Treatment of Psoriasis Vulgaris clinicaltrials.gov\/show\/NCT01536938 (accessed August 2012)"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0329|cit329","unstructured":"Afifi T de Gannes G Huang C Zhou Y Topical therapies for psoriasis: evidence-based review Canadian Family Physician 2005 519 25 15856971"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0330|cit330","unstructured":"Andres P Poncet M Farzaneh S Soto P Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis Journal of Drugs in Dermatology 2006 328 32 16673799"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0331|cit331","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2165\/00019053-200018050-00006","article-title":"Cost-effectiveness analysis of topical calcipotriol versus short-contact dithranol in the treatment of mild to moderate plaque psoriasis","volume":"18","author":"Ashcroft","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0332|cit332","doi-asserted-by":"crossref","unstructured":"Ashcroft DM Po AL Williams HC Griffiths CE Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis BMJ 2000 963 7 10753146","DOI":"10.1136\/bmj.320.7240.963"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0333|cit333","first-page":"81","article-title":"Tacalcitol ointment in the treatment of psoriasis","volume":"139","author":"Aste","year":"2004","journal-title":"Giornale Italiano di Dermatologia e Venereologia"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0334|cit334","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7525-2-12","article-title":"Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease","volume":"2","author":"Atkinson","year":"2004","journal-title":"Health & Quality of Life Outcomes"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0335|cit335","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1067\/S0190-9622(03)00912-5","article-title":"Electronic monitoring of medication adherence in skin disease: Results of a pilot study","volume":"49","author":"Balkrishnan","year":"2003","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0336|cit336","first-page":"107","article-title":"Frequency of psoriatic arthritis in general population and among the psoriatics in department of dermatology","volume":"186","author":"Barisic-Drusko","year":"1994","journal-title":"Acta Dermato-Venereologica. Supplementum."},{"issue":"8761","key":"10.1002\/14651858.CD005028.pub3-BIB0337|cit337","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0140-6736(91)90357-U","article-title":"The pathophysiology of psoriasis","volume":"338","author":"Barker","year":"1991","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0338|cit338","first-page":"199","article-title":"Long-term treatment of psoriasis with calcipotriol scalp solution and cream","volume":"10","author":"Barnes","year":"2000","journal-title":"European Journal of Dermatology"},{"issue":"Suppl 40","key":"10.1002\/14651858.CD005028.pub3-BIB0339|cit339","first-page":"17","article-title":"Immediate and long term effects of topical calcipotriol on calcium homeostasis during treatment of psoriasis [Abstract]","volume":"127","author":"Berth-Jones","year":"1992","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0340|cit340","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2133.1993.tb03168.x","article-title":"Urine Calcium Excretion During Treatment of Psoriasis with Topical Calcipotriol","volume":"129","author":"Berth-Jones","year":"1993","journal-title":"British Journal Of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD005028.pub3-BIB0341|cit341","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/hmg\/7.10.1537","article-title":"The genetics of psoriasis: a complex disorder of the skin and immune system","volume":"7","author":"Bhalerao","year":"1998","journal-title":"Human Molecular Genetics"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0342|cit342","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2133.1998.02367.x","article-title":"Long-Term Outcome of Severe Chronic Plaque Psoriasis Following Treatment with High-Dose Topical Calcipotriol","volume":"139","author":"Bleiker","year":"1998","journal-title":"British Journal Of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0343|cit343","volume-title":"British National Formulary (BNF) 63","author":"Joint Formulary Committee","year":"2012"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0344|cit344","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00002512-199812030-00002","article-title":"Recognition and treatment of psoriasis: special considerations in elderly patients","volume":"12","author":"Bonifati","year":"1998","journal-title":"Drugs & Aging"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0345|cit345","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1046\/j.1365-2133.2002.4653_13.x","article-title":"Topical tacrolimus and pimecrolimus are not associated with skin atrophy","volume":"146","author":"Bos","year":"2002","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0346|cit346","doi-asserted-by":"crossref","unstructured":"Bos JD Spuls PI Topical treatments in psoriasis: today and tomorrow Clinics in Dermatology 2008 432 7 18755361","DOI":"10.1016\/j.clindermatol.2007.10.025"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0347|cit347","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2133.1993.tb03315.x","article-title":"High-dose topical calcipotriol in the treatment of extensive psoriasis vulgaris","volume":"129","author":"Bourke","year":"1993","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0348|cit348","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2265.1994.tb02548.x","article-title":"High dose topical calcipotriol consistently reduces serum parathyroid hormone levels","volume":"41","author":"Bourke","year":"1994","journal-title":"Clinical Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0349|cit349","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archderm.1978.01640180008002","article-title":"Psoriasis in an unselected series of twins","volume":"114","author":"Brandrup","year":"1978","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0350|cit350","unstructured":"Breneman D Sheth P Berger V Naini V Stevens V Phase II clinical trial of bexarotene gel 1% in psoriasis Journal of Drugs in Dermatology 2007 501 6 17679184"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0351|cit351","unstructured":"Brodell RT Bruce S Hudson CP Weiss JS Colon LE Johnson LA A multi-center, open-label study to evaluate the safety and efficacy of a sequential treatment regimen of clobetasol propionate 0.05% spray followed by Calcitriol 3 mg\/g ointment in the management of plaque psoriasis Journal of Drugs in Dermatology 2011 158 64 21283920"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0352|cit352","doi-asserted-by":"crossref","unstructured":"Brownell I Strober BE Folate with methotrexate: big benefit, questionable cost British Journal of Dermatology 2007 213 17578449","DOI":"10.1111\/j.1365-2133.2007.08005.x"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0353|cit353","doi-asserted-by":"crossref","unstructured":"Bruner CR Feldman SR Ventrapragada M Fleischer AB Jr A systematic review of adverse effects associated with topical treatments for psoriasis Dermatology Online Journal 2003 2 12639460","DOI":"10.5070\/D30W66C5GG"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0354|cit354","first-page":"1391","article-title":"Psoriasis","volume-title":"Textbook of Dermatology","author":"Camp","year":"1992"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0355|cit355","doi-asserted-by":"crossref","unstructured":"Carboni I de Felice C Bergamin A Chimenti S Topical use of calcitriol 3 microg\/g ointment in the treatment of mild-to-moderate psoriasis: results from an open-label study Journal of the European Academy of Dermatology & Venereology 2005 11 3 16274406","DOI":"10.1111\/j.1468-3083.2005.01331.x"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0356|cit356","doi-asserted-by":"crossref","unstructured":"Carey W Glazer S Gottlieb AB Lebwohl M Leonardi C Menter A Relapse, rebound, and psoriasis adverse events: an advisory group report Journal of the American Academy of Dermatology 2006 S171 81 16488339","DOI":"10.1016\/j.jaad.2005.10.029"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0357|cit357","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2133.2004.06174.x","article-title":"Better medication adherence results in greater improvement in severity of psoriasis","volume":"151","author":"Carroll","year":"2004","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0358|cit358","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jaad.2004.01.052","article-title":"Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use","volume":"51","author":"Carroll","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0359|cit359","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001213","article-title":"Interventions for guttate psoriasis","author":"Chalmers","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0360|cit360","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001433.pub2","article-title":"Interventions for chronic palmoplantar pustulosis","author":"Chalmers","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD005028.pub3-BIB0361|cit361","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009481","article-title":"Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis","author":"Chen","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1608","key":"10.1002\/14651858.CD005028.pub3-BIB0362|cit362","first-page":"238","article-title":"Better patient compliance in psoriasis","volume":"244","author":"Chu","year":"2000","journal-title":"Practitioner"},{"issue":"Suppl 12","key":"10.1002\/14651858.CD005028.pub3-BIB0363|cit363","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2133.1976.tb02275.x","article-title":"The response of psoriasis to betamethasone valerate and clobetasol propionate: a 6-month controlled study","volume":"94","author":"Corbett","year":"1976","journal-title":"British Journal Of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0364|cit364","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1365-2133.2003.05595.x","article-title":"Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse","volume":"149","author":"Cork","year":"2003","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0365|cit365","doi-asserted-by":"crossref","unstructured":"Cossmann M Welzel J Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial British Journal of Dermatology 2006 700 6","DOI":"10.1111\/j.1365-2133.2006.07369.x"},{"issue":"11","key":"10.1002\/14651858.CD005028.pub3-BIB0366|cit366","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00007611-199611000-00005","article-title":"Long-Term Effectiveness and Safety of Topical Calcipotriene for Psoriasis. Calcipotriene Study Group","volume":"89","author":"Cullen","year":"1996","journal-title":"Southern Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0367|cit367","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0738-081X(97)00023-0","article-title":"The course of psoriasis","volume":"15","author":"Jong","year":"1997","journal-title":"Clinics in Dermatology"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD005028.pub3-BIB0368|cit368","first-page":"193","article-title":"Prednicarbate versus fluocortin for inflammatory dermatoses. A cost-effectiveness study","volume":"12","author":"Tiedra","year":"1997","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0369|cit369","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007633.pub2","article-title":"Interventions for nail psoriasis","author":"Vries","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0370|cit370","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.1975.01630170039002","article-title":"Tachyphylaxis to the action of topically applied corticosteroids","volume":"111","author":"du Vivier","year":"1975","journal-title":"Archives of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0371|cit371","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archderm.1974.01630020023005","article-title":"Natural history of psoriasis in 61 twin pairs","volume":"109","author":"Farber","year":"1974","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0372|cit372","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0190-9622(97)70172-5","article-title":"The economic impact of psoriasis increases with psoriasis severity","volume":"37","author":"Feldman","year":"1997","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0373|cit373","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/120347540000400302","article-title":"Per-gram cost of medication is by itself a poor indicator for comparing costs of different psoriasis treatments: a retrospective cohort study of the cost of psoriasis treatment with topical corticosteroids versus topical calcipotriene","volume":"4","author":"Feldman","year":"2000","journal-title":"Journal of Cutaneous Medicine & Surgery"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0374|cit374","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaad.2007.04.005","article-title":"Adherence to topical therapy increases around the time of office visits","volume":"57","author":"Feldman","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0375|cit375","unstructured":"Feldman SR Effectiveness of clobetasol propionate spray 0.05% added to other stable treatments: add-on therapy in the COBRA trial Cutis 2007 20 8 18154220"},{"issue":"11","key":"10.1002\/14651858.CD005028.pub3-BIB0376|cit376","first-page":"626","article-title":"Reinforcement Therapy in Patients with Psoriasis Treated with Calcipotriol Cream Terapia De Refuerzo En Pacientes Con Psoriasis Tratada Con Calcipotriol","volume":"89","author":"Ferrandiz","year":"1998","journal-title":"Actas Dermo Sifiliograficas"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0377|cit377","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clinical & Experimental Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0378|cit378","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2133.1995.tb05019.x","article-title":"The effect of severe psoriasis on the quality of life of 369 patients","volume":"132","author":"Finlay","year":"1995","journal-title":"British Journal of Dermatology"},{"issue":"6995","key":"10.1002\/14651858.CD005028.pub3-BIB0379|cit379","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1136\/bmj.310.6995.1673","article-title":"Coping with psoriasis","volume":"310","author":"Finlay","year":"1995","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0380|cit380","first-page":"352","article-title":"Psoriasis from the patient's point of view","volume":"137","author":"Finlay","year":"2001","journal-title":"Archives of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0381|cit381","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2005.06502.x","article-title":"Current severe psoriasis and the rule of tens","volume":"152","author":"Finlay","year":"2005","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0382|cit382","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1185\/03007997509114790","article-title":"Comparison of the Response of Psoriasis, over a 6-Month Period, to Clobetasol Propionate and Fluocinolone Acetonide Ointments","volume":"3","author":"Floden","year":"1975","journal-title":"Current Medical Research & Opinion"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0383|cit383","doi-asserted-by":"crossref","unstructured":"Fluhr JW Cavallotti C Berardesca E Emollients, moisturizers, and keratolytic agents in psoriasis Clinics in Dermatology 2008 380 6 18691519","DOI":"10.1016\/j.clindermatol.2008.01.015"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0384|cit384","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/archderm.139.6.752","article-title":"Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy","volume":"139","author":"Fortune","year":"2003","journal-title":"Archives of Dermatology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005028.pub3-BIB0385|cit385","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-3083.2005.01329.x","article-title":"How patients experience psoriasis: results from a European survey","volume":"19","author":"Fouere","year":"2005","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0386|cit386","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/000155599750010373","article-title":"A retrospective study of the teratogenicity of dermatological coal tar products","volume":"79","author":"Franssen","year":"1999","journal-title":"Acta Dermato-Venereologica"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0387|cit387","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2133.1980.tb07658.x","article-title":"Treatment of psoriasis and atopic dermatitis with halcinonide cream applied once and three times daily","volume":"102","author":"Fredriksson","year":"1980","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0388|cit388","doi-asserted-by":"crossref","unstructured":"Genetic Analysis of Psoriasis Consortium the Wellcome Trust Case Control Consortium Strange A Capon F Spencer CC Knight J Weale ME A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 Nature Genetics 2010 985 90","DOI":"10.1038\/ng.694"},{"issue":"Suppl 58","key":"10.1002\/14651858.CD005028.pub3-BIB0389|cit389","first-page":"17","article-title":"Long-term safety of topical calcitriol 3 microg g(-1) ointment","volume":"144","author":"Gerritsen","year":"2001","journal-title":"British Journal Of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0390|cit390","doi-asserted-by":"crossref","unstructured":"Ghoreschi K Weigert C Rocken M Immunopathogenesis and role of T cells in psoriasis Clinics in Dermatology 2007 574 80 18021895","DOI":"10.1016\/j.clindermatol.2007.08.012"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0391|cit391","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/archderm.1931.01450010455012","article-title":"Treatment of psoriasis","volume":"24","author":"Goeckerman","year":"1931","journal-title":"AMA Archives of Dermatology & Syphilology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0392|cit392","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1468-3083.2007.02425.x","article-title":"Adherence to treatment in patients with psoriasis vulgaris: Turkish experience","volume":"22","author":"Gokdemir","year":"2008","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005028.pub3-BIB0393|cit393","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1468-3083.17.s2.1.x","article-title":"The immunological basis of psoriasis","volume":"17","author":"Griffiths","year":"2003","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0394|cit394","doi-asserted-by":"crossref","unstructured":"Griffiths CE Psoriasis: future research needs and goals for the twenty-first century Dermatologic Clinics 2004 493 9 15450345","DOI":"10.1016\/j.det.2003.12.001"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0395|cit395","doi-asserted-by":"crossref","unstructured":"Griffiths CE Christophers E Barker JN Chalmers RJ Chimenti S Krueger GG A classification of psoriasis vulgaris according to phenotype British Journal of Dermatology 2007 258 62 17223864","DOI":"10.1111\/j.1365-2133.2006.07675.x"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0396|cit396","doi-asserted-by":"crossref","unstructured":"Griffiths CE Barker JN Pathogenesis and clinical features of psoriasis Lancet 2007 263 71 17658397","DOI":"10.1016\/S0140-6736(07)61128-3"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0397|cit397","first-page":"339","article-title":"Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders","volume":"61","author":"Gupta","year":"1998","journal-title":"Cutis"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0398|cit398","doi-asserted-by":"crossref","first-page":"263","DOI":"10.12968\/hmed.2007.68.5.23333","article-title":"Psoriasis: maximizing topical treatment concordance","volume":"68","author":"Gupta","year":"2007","journal-title":"British Journal of Hospital Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0399|cit399","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0190-9622(96)90434-X","article-title":"Topical Calcipotriene Has No Short-Term Effect on Calcium and Bone Metabolism of Patients with Psoriasis","volume":"34","author":"Guzzo","year":"1996","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0400|cit400","first-page":"27","article-title":"Cost-Effectiveness Analysis of Calcipotriol Ointment and 'Short-Contact' Dithranol in Treating Mild-to-Moderate Psoriasis","volume":"8","author":"Harrington","year":"1995","journal-title":"British Journal Of Medical Economics"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0401|cit401","volume-title":"Psoriasis. The prevalence in sex, age and occupational groups in total populations in Sweden: morphology, inheritance and association with other skin and rheumatic diseases","author":"Hellgren","year":"1967"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0402|cit402","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2230.1990.tb02038.x","article-title":"Basement Membrane Changes in Psoriatic Patients on Long-Term Topical Corticosteroid Therapy","volume":"15","author":"Heng","year":"1990","journal-title":"Clinical & Experimental Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0403|cit403","doi-asserted-by":"crossref","first-page":"1-15; quiz 16-8","DOI":"10.1016\/j.jaad.2005.01.010","article-title":"Adverse effects of topical glucocorticosteroids","volume":"54","author":"Hengge","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0404|cit404","first-page":"A457","article-title":"Presence of HLA-DR7 in type-I-psoriasis","volume":"40","author":"Henseler","year":"1992","journal-title":"Clinical Research"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0405|cit405","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0406|cit406","first-page":"1","article-title":"Clinical uses for calciotropic hormones 1, 25-dihydroxyvitamin D3 and parathyroid hormone-related peptide in dermatology: a new perspective","volume":"1","author":"Holick","year":"1996","journal-title":"Journal of Investigative Dermatology. Symposium Proceedings"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0407|cit407","unstructured":"Hong E Smith SD Fischer G Evaluation of the atrophogenic potential of topical corticosteroid in dermatology paediatric patients [Abstract]. 43rd Annual Scientific Meeting of the Australasian College of Dermatologists Darwin, NT Australia, 16-19 May 2010 Australasian Journal of Dermatology 2010 A17"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0408|cit408","doi-asserted-by":"crossref","unstructured":"Hong E Smith S Fischer G Evaluation of the atrophogenic potential of topical corticosteroids in pediatric dermatology patients Pediatric Dermatology 2011 393 6 21507057","DOI":"10.1111\/j.1525-1470.2011.01445.x"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0409|cit409","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/bmj.2.4836.591","article-title":"The approach to psoriasis","volume":"2","author":"Ingram","year":"1953","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0410|cit410","doi-asserted-by":"crossref","unstructured":"Jacobi A Braeutigam M Mahler V Schultz E Hertl M Pimecrolimus 1% cream in the treatment of facial psoriasis: a 16-week open-label study Dermatology 2008 133 6 18216475","DOI":"10.1159\/000111510"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0411|cit411","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009687","article-title":"Topical treatments for scalp psoriasis","author":"Jales","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0412|cit412","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1440-0960.2002.00611.x","article-title":"Cost of psoriasis: a study on the morbidity and financial effects of having psoriasis in Australia","volume":"43","author":"Jenner","year":"2002","journal-title":"Australasian Journal of Dermatology"},{"issue":"7303","key":"10.1002\/14651858.CD005028.pub3-BIB0413|cit413","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"Juni","year":"2001","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0414|cit414","doi-asserted-by":"crossref","unstructured":"Kao JS Fluhr JW Man MQ Fowler AJ Hachem JP Crumrine D Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities Journal of Investigative Dermatology 2003 456 64 12603860","DOI":"10.1046\/j.1523-1747.2003.12053.x"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0415|cit415","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0190-9622(87)70105-4","article-title":"Superpotent Topical Steroid Treatment of Psoriasis Vulgaris--Clinical Efficacy and Adrenal Function","volume":"16","author":"Katz","year":"1987","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD005028.pub3-BIB0416|cit416","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0190-9622(89)70082-7","article-title":"Preatrophy: Covert Sign of Thinned Skin","volume":"20","author":"Katz","year":"1989","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0417|cit417","doi-asserted-by":"crossref","unstructured":"Kimball AB Gold MH Zib B Davis MW Clobetasol Propionate Emulsion Formulation Foam Phase IIICSG Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents Journal of the American Academy of Dermatology 2008 448 54 18539358","DOI":"10.1016\/j.jaad.2008.04.020"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0418|cit418","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2133.1988.tb03204.x","article-title":"Improvement of psoriasis by a topical vitamin D3 analogue (Mc 903) in a double-blind study","volume":"119","author":"Kragballe","year":"1988","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0419|cit419","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2340\/0001555571475478","article-title":"Long-Term Efficacy and Tolerability of Topical Calcipotriol in Psoriasis. Results of an Open Study","volume":"71","author":"Kragballe","year":"1991","journal-title":"Acta Dermato-Venereologica"},{"issue":"5 Pt 2","key":"10.1002\/14651858.CD005028.pub3-BIB0420|cit420","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0190-9622(84)80018-3","article-title":"Psoriasis","volume":"11","author":"Krueger","year":"1984","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD005028.pub3-BIB0421|cit421","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1067\/mjd.2000.106374","article-title":"Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?","volume":"43","author":"Krueger","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD005028.pub3-BIB0422|cit422","first-page":"543","article-title":"Economic Analyses of the Treatment of Psoriasis","volume":"6","author":"Lambert","year":"1996","journal-title":"European Journal of Dermatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005028.pub3-BIB0423|cit423","first-page":"S9","article-title":"Cost-Effectiveness of Treatments in Psoriasis","volume":"10","author":"Lambert","year":"1999","journal-title":"Journal Of Dermatological Treatment"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0424|cit424","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000063376","article-title":"Tacalcitol ointment for long-term control of chronic plaque psoriasis in dermatological practice","volume":"204","author":"Lambert","year":"2002","journal-title":"Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0425|cit425","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2133.1996.d01-1009.x","article-title":"A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis","volume":"135","author":"Langner","year":"1996","journal-title":"British Journal of Dermatology"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD005028.pub3-BIB0426|cit426","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0190-9622(96)90349-7","article-title":"A Multicenter Trial of Calcipotriene Ointment and Halobetasol Ointment Compared with Either Agent Alone for the Treatment of Psoriasis","volume":"35","author":"Lebwohl","year":"1996","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD005028.pub3-BIB0427|cit427","first-page":"962","article-title":"Increased occurrence of psoriasis in patients with Crohn's disease and their relatives [comment]","volume":"85","author":"Lee","year":"1990","journal-title":"American Journal of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0428|cit428","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0846.1998.tb00104.x","article-title":"Corticosteroid skin atrophogenicity: assessment methods","volume":"4","author":"Lee","year":"1998","journal-title":"Skin Research & Technology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0429|cit429","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00128071-200607040-00004","article-title":"Pharmionics in dermatology: a review of topical medication adherence","volume":"7","author":"Lee","year":"2006","journal-title":"American Journal of Clinical Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD005028.pub3-BIB0430|cit430","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/0277-9536(85)90173-X","article-title":"Economic Evaluation of New Drug Therapies in Terms of Improved Life Quality","volume":"21","author":"Leu","year":"1985","journal-title":"Social Science & Medicine"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0431|cit431","first-page":"31","volume-title":"Psoriasis, prevalence, spontaneous course and genetics. Published Ph.D Thesis","author":"Lomholt","year":"1963"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0432|cit432","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1046\/j.1365-2133.1999.03207.x","article-title":"Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema","volume":"141","author":"Lundberg","year":"1999","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0433|cit433","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0149-2918(98)80146-X","article-title":"A Pharmacoeconomic Analysis of Topical Therapies for Patients with Mild-to-Moderate Stable Plaque Psoriasis: A US Study","volume":"20","author":"Marchetti","year":"1998","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0434|cit434","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/ng1096-231","article-title":"Evidence that a locus for familial psoriasis maps to chromosome 4q","volume":"14","author":"Matthews","year":"1996","journal-title":"Nature Genetics"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0435|cit435","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2133.2003.05492.x","article-title":"Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials","volume":"149","author":"McKenna","year":"2003","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0436|cit436","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1523-1747.1998.00128.x","article-title":"Vitamin D receptor polymorphism and calcipotriol response in patients with psoriasis","volume":"110","author":"Mee","year":"1998","journal-title":"Journal of Investigative Dermatology"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD005028.pub3-BIB0437|cit437","first-page":"12","article-title":"Topical monotherapy with clobetasol propionate spray 0.05% in the COBRA trial","volume":"80","author":"Menter","year":"2007","journal-title":"Cutis"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0438|cit438","first-page":"463","article-title":"Long-term safety and efficacy of high-concentration (20 microg\/g) tacalcitol ointment in psoriasis vulgaris","volume":"12","author":"Miyachi","year":"2002","journal-title":"European Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0439|cit439","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2340\/000155557296299","article-title":"Treatment of psoriasis vulgaris with topical calcipotriol has no short-term effect on calcium or bone metabolism. A randomized, double-blind, placebo-controlled study","volume":"73","author":"Mortensen","year":"1993","journal-title":"Acta Dermato-Venereologica"},{"issue":"8","key":"10.1002\/14651858.CD005028.pub3-BIB0440|cit440","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/hmg\/6.8.1349","article-title":"Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan","volume":"6","author":"Nair","year":"1997","journal-title":"Human Molecular Genetics"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0441|cit441","volume-title":"Undertaking Systematic Reviews of Research on Effectiveness: CRD guidelines for those Carrying Out or Commissioning Reviews","volume":"CRD Report Numb","author":"NHS Centre for Reviews & Dissemination","year":"2001"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0442|cit442","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/120347549700200103","article-title":"Calcipotriol in the Treatment of Psoriasis of Limited Severity: Pharmacoeconomic Evaluation","volume":"2","author":"Oh","year":"1997","journal-title":"Journal of Cutaneous Medicine & Surgery"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005028.pub3-BIB0443|cit443","first-page":"2s19","article-title":"Psoriasis: evaluation of quality of life","volume":"127","author":"Ortonne","year":"2000","journal-title":"Annales de Dermatologie et de Venereologie"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0444|cit444","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1468-3083.2002.00432.x","article-title":"The importance of accurate dosage of topical agents: a method of estimating involved area and application to calcipotriol treatment failures","volume":"16","author":"Osborne","year":"2002","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0445|cit445","first-page":"52","article-title":"Healthy returns come from costly drug - prescribing an expensive drug may be the most cost-effective way to treat patients","volume":"January","author":"Owen","year":"1993","journal-title":"Healthcare Management"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0446|cit446","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001976","article-title":"Antistreptococcal interventions for guttate and chronic plaque psoriasis","author":"Owen","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0447|cit447","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/000155502753601019","article-title":"Allergic contact dermatitis from calcipotriol","volume":"82","author":"Park","year":"2002","journal-title":"Acta Dermato-Venereologica"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0448|cit448","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/09546639109086763","article-title":"Medicated Tape Versus Cream Formulation - a Major Saving of Fluocinolone Acetonide","volume":"1","author":"Parodi","year":"1991","journal-title":"Journal Of Dermatological Treatment"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0449|cit449","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/09546639309089517","article-title":"Long-Term Treatment of Chronic Plaque Psoriasis with Calcipotriol","volume":"4","author":"Poyner","year":"1993","journal-title":"Journal Of Dermatological Treatment"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0450|cit450","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/09546639909055907","article-title":"Economic Impact of Psoriasis Treatment on the Patient and on the National Health Service","volume":"10","author":"Poyner","year":"1999","journal-title":"Journal Of Dermatological Treatment"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0451|cit451","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1468-3083.2000.00034.x","article-title":"Patient attitudes to topical antipsoriatic treatment with calcipotriol and dithranol","volume":"14","author":"Poyner","year":"2000","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0452|cit452","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000246851","article-title":"Long-Term Use of Topical Calcipotriol in Chronic Plaque Psoriasis","volume":"189","author":"Ramsay","year":"1994","journal-title":"Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0453|cit453","first-page":"581","article-title":"Patients with psoriasis and their compliance with medication","volume":"41","author":"Richards","year":"1999","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0454|cit454","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2133.2003.05391.x","article-title":"Stigmatization and psoriasis","volume":"149","author":"Richards","year":"2003","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0455|cit455","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1468-3083.2006.01565.x","article-title":"Adherence to treatment in patients with psoriasis","volume":"20","author":"Richards","year":"2006","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0456|cit456","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008947","article-title":"Ustekinumab for plaque psoriasis","author":"Roberts","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0457|cit457","doi-asserted-by":"crossref","unstructured":"Roelofzen JH Aben KK Oldenhof UT Coenraads PJ Alkemade HA van de Kerkhof PC No increased risk of cancer after coal tar treatment in patients with psoriasis or eczema Journal of Investigative Dermatology 2010 953 61 20016499","DOI":"10.1038\/jid.2009.389"},{"issue":"15","key":"10.1002\/14651858.CD005028.pub3-BIB0458|cit458","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJM197210122871503","article-title":"Histocompatibility (HL-A) antigens associated with psoriasis","volume":"287","author":"Russell","year":"1972","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD005028.pub3-BIB0459|cit459","first-page":"1499","article-title":"Prevalence of psoriatic arthritis in Italian psoriatic patients","volume":"22","author":"Salvarani","year":"1995","journal-title":"Journal of Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0460|cit460","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1046\/j.1365-2133.2003.05156.x","article-title":"Willingness to pay and time trade-off: sensitive to changes of quality of life in psoriasis patients?","volume":"148","author":"Schiffner","year":"2003","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0461|cit461","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/09546639209092738","article-title":"A Cost-Comparison Study: Ulobetasol Versus Clobetasol in Severe Localized Psoriasis","volume":"2","author":"Schwicker","year":"1992","journal-title":"Journal Of Dermatological Treatment"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0462|cit462","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/archderm.1983.01650290003002","article-title":"Topical fluocinonide and tachyphylaxis letter","volume":"119","author":"Senter","year":"1983","journal-title":"Archives of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0463|cit463","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/jid.1949.42","article-title":"Additional studies on psoriasis in the tropics and in starvation camps","volume":"12","author":"Simons","year":"1949","journal-title":"Journal of Investigative Dermatology"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD005028.pub3-BIB0464|cit464","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1067\/mjd.2000.105167","article-title":"Topical therapy for psoriasis with the use of augmented betamethasone and calcipotriene on alternate weeks","volume":"43","author":"Singh","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0465|cit465","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S1098-3015(10)61462-3","article-title":"Pharmacoeconomic evaluation of a new two compound ointment (Daivobet (R)) and calcipotriol (Daivonex (R)) in the treatment of psoriasis vulgaris in Sweden","volume":"5","author":"Sorensen","year":"2002","journal-title":"Value Health"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0466|cit466","first-page":"473","article-title":"The Benefits, Costs and Risks of Topical Tar Preparations in the Treatment of Psoriasis: Considerations of Cost Effectiveness","volume":"17","author":"Stern","year":"1988","journal-title":"Annals Of The Academy Of Medicine, Singapore"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0467|cit467","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0733-8635(18)30036-6","article-title":"Epidemiology of psoriasis","volume":"13","author":"Stern","year":"1995","journal-title":"Dermatologic Clinics"},{"issue":"9074","key":"10.1002\/14651858.CD005028.pub3-BIB0468|cit468","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(97)05257-4","article-title":"Psoriasis","volume":"350","author":"Stern","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0469|cit469","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2133.1977.tb05187.x","article-title":"A separation of clinical from epidermal thinning effect in the topical glucocorticoid clobetasone butyrate","volume":"96","author":"Stevanovic","year":"1977","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0470|cit470","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2133.1974.tb15859.x","article-title":"HL-A in psoriasis vulgaris and in pustular psoriasis - population and family studies","volume":"91","author":"Svejgaard","year":"1974","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0471|cit471","first-page":"221","article-title":"Psoriasis: Patient-oriented treatment improves compliance","volume":"15","author":"Szeimies","year":"2004","journal-title":"Haut"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0472|cit472","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0738-081X(97)00024-2","article-title":"Triggering factors","volume":"15","author":"Tagami","year":"1997","journal-title":"Clinics in Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0473|cit473","doi-asserted-by":"crossref","unstructured":"Taylor W Gladman D Helliwell P Marchesoni A Mease P Mielants H Classification criteria for psoriatic arthritis: development of new criteria from a large international study Arthritis & Rheumatism 2006 2665 73 16871531","DOI":"10.1002\/art.21972"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0474|cit474","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/hmg\/8.6.1135","article-title":"Novel genetic association between the corneodesmosin (MHC S) gene and susceptibility to psoriasis","volume":"8","author":"Tazi Ahnini","year":"1999","journal-title":"Human Molecular Genetics"},{"issue":"9178","key":"10.1002\/14651858.CD005028.pub3-BIB0475|cit475","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0140-6736(05)77950-2","article-title":"Corneodesmosin (MHC S) gene in guttate psoriasis","volume":"354","author":"Tazi-Ahnini","year":"1999","journal-title":"Lancet"},{"issue":"5162","key":"10.1002\/14651858.CD005028.pub3-BIB0476|cit476","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1126\/science.8178173","article-title":"Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q","volume":"264","author":"Tomfohrde","year":"1994","journal-title":"Science"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0477|cit477","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000071788","article-title":"The atrophogenic potential and dermal tolerance of calcipotriol\/betamethasone dipropionate ointment compared with betamethasone dipropionate ointment","volume":"207","author":"Traulsen","year":"2003","journal-title":"Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0478|cit478","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/hmg\/6.5.813","article-title":"Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis","volume":"6","author":"Trembath","year":"1997","journal-title":"Human Molecular Genetics"},{"issue":"12","key":"10.1002\/14651858.CD005028.pub3-BIB0479|cit479","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ng.2467","article-title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","volume":"44","author":"Tsoi","year":"2012","journal-title":"Nature Genetics"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0480|cit480","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000069959","article-title":"Histometric assessment of psoriatic plaques treated by vitamin D3 derivatives","volume":"206","author":"Uhoda","year":"2003","journal-title":"Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0481|cit481","first-page":"116","article-title":"Cignolin als Heilmittel der Psoriasis","volume":"62","author":"Unna","year":"1916","journal-title":"Dermatologische Wochenschrift"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005028.pub3-BIB0482|cit482","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.3109\/09546639609080597","article-title":"A Long-Term Assessment of the Safety and Tolerability of Calcitriol Ointment in the Treatment of Chronic Plaque Psoriasis","volume":"7","author":"Kerkhof","year":"1996","journal-title":"Journal Of Dermatological Treatment"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0483|cit483","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0738-081X(97)00010-2","article-title":"Combinations and comparisons","volume":"15","author":"Kerkhof","year":"1997","journal-title":"Clinics in Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0484|cit484","first-page":"421","article-title":"Long-Term Efficacy and Safety of Once Daily Treatment of Chronic Plaque Psoriasis with Tacalcitol Ointment","volume":"7","author":"Kerkhof","year":"1997","journal-title":"European Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0485|cit485","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000029803","article-title":"An update on vitamin D3 analogues in the treatment of psoriasis","volume":"11","author":"Kerkhof","year":"1998","journal-title":"Skin Pharmacology & Applied Skin Physiology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0486|cit486","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000017972","article-title":"Evaluation of topical drug treatment in psoriasis","volume":"197","author":"Kerkhof","year":"1998","journal-title":"Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0487|cit487","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000018390","article-title":"Patient compliance and disease management in the treatment of psoriasis in the Netherlands","volume":"200","author":"Kerkhof","year":"2000","journal-title":"Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0488|cit488","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/095466301317085345","article-title":"Calcipotriol cream in the morning and ointment in the evening: a novel regimen to improve compliance","volume":"12","author":"Kerkhof","year":"2001","journal-title":"Journal of Dermatological Treatment"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0489|cit489","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1365-2133.2002.04567.x","article-title":"Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis","volume":"146","author":"Kerkhof","year":"2002","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0490|cit490","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2133.2004.06134.x","article-title":"The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet\/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial","volume":"151","author":"Kerkhof","year":"2004","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0491|cit491","doi-asserted-by":"crossref","unstructured":"Van de Kerkhof PC Barker J Griffiths CE Kragballe K Mason J Menter A Psoriasis: Consensus on topical therapies Journal of the European Academy of Dermatology & Venereology 2008 859 70 18081748","DOI":"10.1111\/j.1468-3083.2007.02534.x"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0492|cit492","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jaad.2004.05.020","article-title":"Dermoscopic assessment of long-term topical therapies with potent steroids in chronic psoriasis","volume":"51","author":"Vazquez-Lopez","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005028.pub3-BIB0493|cit493","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007633","article-title":"Interventions for nail psoriasis","author":"Velema","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0494|cit494","doi-asserted-by":"crossref","unstructured":"Veraldi S Caputo R Pacifico A Peris K Soda R Chimenti S Short contact therapy with tazarotene in psoriasis vulgaris Dermatology 2006 235 7 16549919","DOI":"10.1159\/000091250"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0495|cit495","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.0906-6705.2004.00151.x","article-title":"The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis","volume":"13","author":"Vissers","year":"2004","journal-title":"Experimental Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD005028.pub3-BIB0496|cit496","first-page":"19","article-title":"Helping people to remain in control of their psoriasis","volume":"4","author":"Watts","year":"1998","journal-title":"Community Nurse"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0497|cit497","volume-title":"On cutaneous diseases","author":"Willan","year":"1808"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0498|cit498","doi-asserted-by":"crossref","unstructured":"Wishart JM Calcitriol (1 alpha,25-dihydroxyvitamin D3) ointment in psoriasis, a safety tolerance and efficacy multicentre study Dermatology 1994 135 9 8136540","DOI":"10.1159\/000247118"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0499|cit499","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0190-9622(84)80314-X","article-title":"The prevalence of psoriasis in the Mongoloid race","volume":"10","author":"Yip","year":"1984","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD005028.pub3-BIB0500|cit500","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1046\/j.1365-2133.2002.04742.x","article-title":"Quality of life in 6497 Nordic patients with psoriasis","volume":"146","author":"Zachariae","year":"2002","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD005028.pub3-BIB0501|cit501","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/archderm.140.4.408","article-title":"Objective assessment of compliance with psoriasis treatment","volume":"140","author":"Zaghloul","year":"2004","journal-title":"Archives of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD005028.pub3-BIB0502|cit502","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-4362.1992.tb02696.x","article-title":"Joint complaints in psoriasis patients","volume":"31","author":"Zanolli","year":"1992","journal-title":"International Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD005028.pub3-BIB0503|cit503","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archderm.1995.01690170063009","article-title":"Assessing the Preferences of Patients with Psoriasis: A Quantitative, Utility Approach","volume":"131","author":"Zug","year":"1995","journal-title":"Archives of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD005028.pub3-BIB0504|cit504","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2133.2000.04713.x","article-title":"Topical preparations for the treatment of psoriasis: a systematic review","volume":"146","author":"Mason","year":"2002","journal-title":"British Journal Of Dermatology"},{"key":"10.1002\/14651858.CD005028.pub3-BIB0505|cit505","article-title":"Topical preparations for the treatment of psoriasis in primary care: a systematic review","volume-title":"University of York (OP41)","author":"Mason","year":"2002"},{"issue":"2","key":"10.1002\/14651858.CD005028.pub3-BIB0506|cit506","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005028.pub2","article-title":"Topical treatments for chronic plaque psoriasis","author":"Mason","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005028.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T07:02:30Z","timestamp":1720249350000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005028.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,28]]},"references-count":506,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005028.pub3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717995783.793478451","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,28]]}}}